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In the cat, the tibialis anterior (cranialis) muscle is classified as a 
"fast" muscle made up of predominantly white fibers (Denny-Brown, 1929). 
The twitch speed of the tenuissimus muscle was compared to that of the 
· tibialis and found to be slightly slower. With regard to speed of con-
traction, Denny-Brown believed that the red pigmentation which is merely 
due to the muscle content of hemogl~bin or myoglobin is not essential to its 
typically slower type of contracti~n. More recently Csilik (1967) compared 
red and white muscle as to cholinesterase activity and pointed out some 
subtle differ~nces between these muscle types. The tibialis muscle reaches 
its peak contraction in about 20 msec with an overall duration of 80 msec 
while the corresponding values for the tenuissimus were 30 and 100 msec, 
respectively (Maclagen, 1962). Both muscles had about the same fusion 
frequency and a marked potentiation of the maximal contractions occurred 
post-tetanically in both cases, irrespective of the duration of the tetanus 
or the frequency of stimulation. 
The tibialis muscle in the cat (Fig. 1) and in man can be located in 
the lower limb by its insertion at the first metatarsal of the foot and also 
by its origin at the proximal parts of the tibia and fibula. It is a superficial 
muscle covering the lateral side of the cranial part of the tibia and ending 
as a strong tendon which passes beneath the transverse crural ligament 
(Crouch, 1969). A cross-section of the muscle shows that it consists of 
alx;ut 16, 000 fibers (Porter and Hart, 1923). It is innervated by the 
c.rural f-,.,scia, i. 
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, peroneal nerve which arises from the sciatic. Further information 
regarding the branching of this nerve within the muscle is not available. 
This may be due to the larger size of the muscle in comparison to the 
tenuissimus making more discrete anatomical observation difficult. I 
would assume that the motor unit, i.e. the individual motor nerve fiber 
together with the multitude of muscle fibers it innervates would have 
properties similar to that described for the tenuissimus. As with other 
skeletal muscles, it is generally agreed that skeletal muscle fibers do not 
receive a direct sympathetic innervation (Bowman and Nott, 1969). 
The main action of this muscle is in the flexion ?f the foot; 
secondarily, it also acts to extend the second- digit and rotate the paw 
laterally. Sherrington (1910) noted that this muscle was involved in the 
reflex flexion of the hind limb. The muscle would contract inflexion and 
relax during the extension phase of the step-reflex. He also observed th
0
at 
during the standing reflex there is an absence of contraction in the tibialis 
anterior. In the same study, Sherrington reported on the tenuissimus 
muscle of the cat. It was very similar in its action to that of the tibialis 
anterior differing only as to the degree of contraction or relaxation. 
The tenuissimus muscle (abductor cruris caudalis; Fig. 2) is a 
long slender muscle running frem the second caudal vertebra to an 
insertion halfway down the leg on the fascia of the biceps femoris (Adrian, 
1925). Its action is that of a weak abductor and extensor of the thigh as well 
._ ______________________ __,.._..,_ _________ M-..OW....,_....,.. ..... _________________________ ....,. 
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as a flexor of the thigh. The muscle is absent in man and is not found in 
all cats. It varies from about 9 to 15 cm in length and its cross section 
contains about 1000 fibers. The muscle fibers are parallel; there are no 
tendonous intersections of any kind. Each fiber is on the average 17. 3 mm 
long, with extremes from 13. 0 to 25. 5 mm. The mean diameter of each 
fiber is about 30 microns (Boyd, 1956). 
The arrangement of the tenuissimus makes it a suitable muscle for 
illustrating the response of a complex muscle whose fibers do not stretch 
from end to end. 
The spread of activity throughout the muscle wh.en one point is 
stimulated is due to an excitation of nerve fibers which branch out in such 
a way that one fiber of the main nerve trunk may be connected with muscle 
fibers at either end of the muscle. The main nerve fiber divides into two 
branches which enter the muscle slightly proximal to its center, one 
passing upwards and the other downwards (Adrian, 1925). Brown (1918) has 
suggested the possibility that within the neuron there are units, the 
activation of which are "all or none" in character. This possibility was 
shown to be true in 1923 by Porter and Hart, who showed that the nerve-
muscle responses were comparable to the "all or none" responses obse~rved 
. via reflex activity. Cooper (19'e9) concluded that each branch of the nerve 
c:::~.chain of muscle fibers rath.:~h~n-~~~.:==ide :=~-
llJll' -------------------------~7---------------------------, 
Thus, in a submaximal contraction both halves of the muscle may contract 
with each half contracting throughout its length, while in the course of a 
larger contraction more parallel chains are brought into action. 
The nerve branch to the muscle fiber loses its myelin sheath before 
it penetrates the sarcolemma. Zacks and Blumberg (1961) observed terminal 
axon branches lying in depressions (primary synaptic clefts) in the 
sarcoplasmic surface. Overlying the terminal branches and intimately 
related to the axon mc:mbrane was a mass of Schwarm cell cytoplasm that 
occasionally .showed complex infoldings with the axon surface membrane. 
The primary synaptic clefts contained a frequently laminated and somewhat 
gram1lar material of low electron density that has been called "ground 
substance" (deHarven and Coers, 1959), "basement membrane" (Robertson, 
1960) or "amorphous surface material" (Zacks and Blumberg, 1961). 
The motor endplates of the tenuissimus conform to the description 
given for other mammalian endplates (Boyd, 1956). Coers and Wolf (1959) 
estimated the mean diameter of the human limb muscle motor endplates to 
·be 32. 2+10. 5µ. individual motor endplates ranged in diameter from 
10 to 80p. They were also able to demonstrate a close direct correlation 
between the diameter of the muscle fibers and their respective endplate~ 
diameter. Coers (1955) ccmpafed in the rabbit and monkey the size of 
I 
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endplates in red muscle, the soleus vs. that of the endplates in white 
muscle, the anterior tibialis, and found the red muscle endplates to have 
a mean size significantly greater than that of the white muscle endplates. 
Using rat muscle, Palade and Palay (1954) concluded that the axon 
ending anatomically appeared the same as that of central synapses. Reger 
(1957) compared the ultrastructure of normal and denervated neuromuscular 
synapses in the mouse. Forty-eight hours following the denervation ther·e 
was a retraction of the sarcolemma with considerable lysis observed at 
the axon and its contents. The normal neuromuscular synapse consisted of 
a sarcoplasmic sole with a large accumulation of mitochondria and small 
granules. The axon and the muscle were separated by a cleft of about 
500 - 700A. Synaptic vesicles, mean diameter 300.A, were particularly 
numerous at the periphery of nerve endings in the region facing the muscle 
.fiber, where they numbered up to 250/µ 2 (deHarven and Coers, 1959). 
Bennett (1956) postulated a membrane vesiculation mechanism for 
transfer of substances across cell membranes. De Robertis (1958) 
amplified this concept to suggest a mechanism for release of neurotrans-
mitters via vesicular interaction of pre- and post-synaptic membranes. A 
number of neurophysiologists and pharmacologists have modified this 
' 
proposed mechanism in describing the transmitter release mechanisms at 
synaptic junctions (Katz, 1958, 1962; Bass and Moore, 1966; Hubbard 
et al. , 1967). 
p 
9 
Reports on.the ultrastructure of the neuromuscular junction never 
describe whole synaptic vesicles crossing synaptic clefts. What's more, 
what is the substance that lies within the synaptic cleft? Is this substance 
or fluid comparable to normal extra"'"cellular substance? What in fact 
happens to vesicles once they reach the presynaptic membrane or are ex-
pelled from the nerve terminal? Wh~t effect do drugs have on the "normal" 
anatomy of the neuromuscular junction? 
' 
I 
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Basic Properties of Nerve-Muscle Membranes and of Transmission 
At the beginning of this century, Bernstein (1902) published his 
membrane theory of nervous conduction. Since the action potential involves 
a reversal of membrane potential and is not simply a neutralization as 
Bernstein proposed, his theory has had to be modified in one important 
respect. But, in general, Bernstein.'s theory has stood the test of time 
better than most biological theories and the underlying assumptions about 
the role of the membrane, which probably seemed speculative to 
Bernstein's c;omtemporaries would now be accepted without question by 
the majority of physiologists (Hodgkin, 1965). 
In 1949, Hodgkin determined by biochemical analysis that the fluid 
external to either a nerve or muscle contained high concentrations of sodium 
and chloride, while the intracellular ionic composition showed a higher 
concentration of potassium and various organic anions. There are several 
factors which may affect the rate of exchange of these ions across their 
respective membranes. One of these is the actual potential difference or 
electrical gradient across the cell membrane. This produces a tendency 
for equilibration of ions according to their respective electrical nature . 
• ~ s a result, cations entering the membrane are attracted by the negati~e 
charges with.in the cell and in fa'ct tend to be driven into the cell; while 
anions within the cell for the same reason tend to pass to the outside through , 
the cc:~=~~r~~:-=:s stu-~i: .. ~ave -s=~~a~.~he cell ==~:J 
p 
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its resting state is selectively permeable to the potassium ion which results 
in a gradual loss by leakage of potassium to the outside of the cell. These 
same studies have shown that the nerve cell membrane exhibits slight 
permeability for either the sodium or chloride ion but that such is not the 
. case for the larger organic anions. On the other hand, Hodgkin and 
Horowicz (1959) have demonstrated that the muscle cell membrane exhibits 
a greater permeability to chloride ions than is evidenced at the nerve cell 
membrane. To maintain a relatively steady state of potassium ions within 
and sodium ions without the cell, a metabolic pumping mechanism, the 
sodium pump, has been suggested. If one calculates the potential differ-
ences across these cell membranes by using either the Nernst or Goldman 
equation, one can see a rather good agreement with the empirical 
observations obtained using standard electrophysiological procedures. 
The generation of a nervous impulse is like starting a fire, i.e. it 
requires a spark which in the case of the membrane is constituted by the 
depolarization. This depolarization is of such a nature that once it reaches 
threshold, a non-decremental, "all-or-nothing" phenomenon occurs, the 
I action potential. The development of this initial depolarization to threshold may be electrical, chemical, or mechanical in nature depending 
~ 
upon the specific sensitivity of tl:te membrane components involved. In the 
case of the neuromuscular junction the postsynaptic membrane - the 
endplate ar.ca - is strictly chemically sensitive {Katz, 1966). Having reached 
.t. ------~..-!elOH'~~~-·t------·-· .. -·-·-·-··----.... ----\i!fii .......... ~,,..,.,. _______ , _______ ~ 
~----·------~13------------------. 
threshold via depolarization, the cell membrane develops a high specific 
permeability to sodium ions resulting in the influx of the positively charged 
sodium ion within a fraction of a millisecond. The increased permeability 
to sodium is said to be due to a physical-chemical change of the membrane. 
As a consequence sodium ions are carried inwardly along their steep 
electro- chemical gradient, rapidly tj.is charging the cell membrane in a 
feed-forward type of action whicl?- progressively self-regenerates their 
transfer. The net result is the production of the "overshoot" type of 
potential, i.e. a reversal of potential approximating but never reaching the 
sodium equilibrium potential (ENa). This self-regenerating increase in 
sodium permeability beginning at threshold does not continue indefinitely. 
There is an inactivation process whereby this transfer process begins to 
fail as the action potential reaches its peak; the nature of this inactivation 
process is not understood. It has been shown that the amplitude of the 
action potential is determined by the ratio [Na0 l to [NaJ (Hodgkin and 
Katz, 1949). 
It must be kept in mind that potassium ions tend to leave the cell 
not only in the resting state; but moreso, also during the action 
potential. As the action potential tends towards the ENa' a similar 
increase in permeability, this time to potassium ion, occurs causing an 
I 
, _______ , __ 
____ , _____________________________________________________ _ 
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increased leakage of potassium out of the cell. In time the Na-pump will 
act to restore any imbalance in Na/K concentrations within the cell. The 
magnitude of the net ionic fluxes was shown to be equal to 3 to 4 pmoles I 
impulse-cm2 which is greater than twice the safety factor for conduction 
(Hodgkin, 1958). Also aiding in the movement of potassium out of the cell is I · 
the increased electrical gradient resulting from the elevated sodium ion 
copcentration. Combining with the decreased sodium permeability and 
increased activity of the sodium-pump, the outward movement of potassium 
returns the membrane potential back to its resting level (Hocgkin, 1867) -
a negative feedback process (Katz, 1966). It should be noted that at the 
termination of the falling phase of the action potential, i.e. during 
I 
I 
I 
I repolarization, the action potential may or may not have a positive after- ; 
The positive I potential (a potential more negative than the resting potential). 
after-potential, if it occurs, depends on the resting membrane potential 
of the cell being studied. For example, the muscle membrar.e would not 
normally show a positive after-·potential since the potassium equilibrium 
potential (EK) approximates the resting potential. However, at most 
r other excitable membranes a positive after-pote~1ti.al is seen dt:e to the EK 
being more negative than ~he resting potential and thereby pushing the action 
. ' 
, poi:err':ial 1:owa:i:ds this ''<-1.lJf· dudri.g repolariz~itbn (Hodgkin, 1951). Also, 
; l in excised preparations the i·ecorded resting p8tcntial is usually more posi-
I 
I 
l 
1. 
l 
f Uve than that of the normal tissue due to a non-steady stctte of the excised j 
! . ~ 
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preparation (Katz, 1966). One can induce a positive after-potential in any 
preparation by simply depolarizing that cell to a level more positive than 
the resting potential (by using a voltage clamp) and therefore away from 
the EK (Cole, 1961). In using the cut fiber preparation one can readily see 
a positive after-potential since the resting potentials are in the range of 
-40 to -50 mV compared to the normal potential of -60 to -70 mV. 
During the time of the positive after-potential a state of refractoriness 
can be noted at the membrane. At this time the membrane permeability to 
sodium ion is minimal while that towards potassium ion is still quite 
apparent - trying to push the potential toward the valu.e of the EK. However, 
this refractory state is short lived allowing the normal regenerative 
mechanism of the action potential to proceed once the membrane potential 
has returned to its resting state (Hodgkin, 1967). 
There are several stages of neuromuscular transmission that occur 
during the transfer of information from nerve to muscle. Altogether, 
six stages may be distinguished: 1) the nerve impulse; 2) nerve ending 
depolarization; 3) transmitter release; 4) endplate potential; 5) muscle 
action potential and 6) muscle contraction. It has been shown that even 
without a conducted nerve impulse, the transmitter quanta, i.e. the mepps, 
.,_ 
act across the synapse on the p'tlstsynaptic membrane. But only after a 
nerve impulse has been generated which sufficiently releases enough 
transmitter to evoke a graded endpl8.te potential of threshold magnitude 
16 
will a muscle action potential be propagated. There is a certain delay 
between nerve impulse and the recording of an endplate potential. This 
delay has been attributed mainly to the release mechanism for the 
transmitter (Katz and Miledi, 1965). However, other factors that may be 
suggested to contribute to this delay are the actual diffusion of the trans -
mitter across the junctional cleft an~ also the receptor activation or 
permeability changes. Through the combined efforts of several researchers 
·the nature of the transmitter at the neuromuscular junction has been 
suggested to be cholinergic. 
Concept of Neurohumoral Transmission 
The idea of neurohumoral transmission was first proposed by T. R. 
Elliott (1905). He was impressed with the similarity in action of adrenalin 
and the effect of stimulation of sympathetic fibers. As a result, he pro-
posed that adrenalin may be the transmitter from sympathetic nerves to 
their effector organs. A comparable role was later suggested for 
acetylcholine in parasympathetic nerve endings by Hunt and Taveau (1906); 
this concept was greatly extended by Dale (1914). These proposals were 
fortified by Otto Loewi's (1921) experiments on the frog's heart vagus a12_d 
on the perfusate in which Loewi has demonstrated the presence of the 
"Vagus-Stoff". Finally, in 1929, Dale and Dudley isolated acetylcholine 
from the spleen establishing it as a naturally occurring substance and 
~---· -------------------------------, 17 
concluded that acetylcholine was the parasympathetic transmitter. Although 
the concept of neurohumoral transmission appeared acceptable to many 
physiologists in the case of the autonomic nervous system, it was not 
received favorably when it was proposed for the neuromyal junction. 
However, in 1936, Dale, Feldberg, and Vogt showed that the chemical 
concerned with neuromuscular transmission was also acetylcholine (cf. 
Karczmar, 1970, for the history of the development of t~e concept of 
neuro-transmission). The nerve fibers innervating skeletal muscle have 
been classified as cholinergic; since their action is not blocked by atropine 
nor is their action mimicked by the alkaloid muscarine their effector site 
has been classified as nicotinic in its response. 
Cholinergic nerve endings contain many enzymes of which two are of 
prime importance. Choline acetylase (or choline transferase) synthesizes 
acetylcholine by transfering acetyl groups from CoEnzymeA to choline. 
This enzyme is contained within the cytoplasm of the axon in intracellular 
particles other than the vesicles (Hebb and Smallman, 1956). Choline is 
normally present in sufficiPnt plasma concentration to support optimal 
synthesis no matter how heavy the frequ<:>ncy of nerve impulses might be 
(Bowman, 1962).. Choline is unable to penetrate nerve axons along their ... 
length so that a specific choline transport mechanism within the nerve 
terminal is requh:-ed. This transport mechanism carries extracellular 
choline to the terminal where it is acetylated by choline acetylase. The 
___________ __.._,,, ______________ _ 
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second prime enzyme which is contained in the nerve terminal is 
acetylcholinesterase (AcChE). This enzyme is capable of rapidly hydro-
lyzing and thereby inactivating acetylcholine (ACh). AcChE unlike choline 
acetylase has been localized at the external surface of the pre- and 
post-synaptic membranes (Koelle and Friedenwald, 1949). A third location 
has been suggested (Mann, Tennenbaum and Quastel, 1938); AcChE may 
be located inside the nerve-endings where it is possibly associated with 
the outer surface of the vesicles or the inner surface of the presynaptic 
membrane. There is, however, a distribution difference depending upon 
the tissue studied. At the neuromuscular junction most of the enzyme 
AcChE is located postsynaptically (Couteaux. 1958; Riker, 1960; Barnett, 
1962). Koelle and Steiner (1956) have suggested that external AcChE is the 
functional type, which acts to hydrolyze ACh released during transmission; 
the internal AcChE is the recently synthesized enzyme on its way to the 
functional external sites. These two enzymes, choline acetylase and 
AcChE, are probably formed in the cell body and are carried down the 
nerve-endings by the axoplasmic current streaming down each fiber (Hebb 
and V\"aites, 1956). 
Onee the transmitter /~Ch has been synthesized it may be distributed 
at the nerve terminal into varioos compartments (Birks and Macintosh, 
1961). It is found that only part of the transmitter present can be released I 
by n·2rve impulsr:s. At the rat diaphragm as much as 75 - 85% of the total I 
I -----~~~-~_._ • ....--... JDIW!ll .. 1...,,..,,~.-.... Jt••-...,W.Alldra-... ._~1' ... ll:.-..uir:...,• • =-1'C91~·-lff!ll,-,..-~~_. 
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present is releasp.ble (Potter, 1968). Potter also reported that in the 
release process the most recently synthesized ACh is released first. What's , 
physiological; it was observed that the amount released per impulse is not 
( 
I 
I 
constant but is dependent upon the frequency of stimulation (Starne, Hedqvist 
rnore, the transmitter that is releasable is not apparently equally available. 
This has been demonstrated by stimulating nerves at frequencies other than 
and Bygdeman, 1969; Folkow, Haggendal and Lisander, 1968). Using a 
technique in which trains of endplate potentials (epps) are observed, a fast 
depletion of ACh output during the beginning of such a stimulation seems 
to occur, leveling off to a mobilized release level characterized by a slower 
depletion of ACh (Liley and North, 1953; Elmqvist and Quastel, 1965). These 
latter results point to a further compartmentalization of the terminal 
into a smaller, readily releasable store that can be maintained by a larger 
less mobile store (Perry, 1953; Birks and Macintosh, 1961; Elmqvist and 
Quastel, 1965). The most mobile store may be the closest to the presynaptic 
membrane (Curtis and Eccles, 1960), but this suggestion has not yet been 
~ sho\vn to be true. 
I 
Transmitter Release 
The transmitter having b~en compartmentc.lized is ready for release. 
But there are two different manners in which this is accomplished, namely 
spontaneously or by nerye impulse. Spontaneous transmitter release 
(originally classified as "biological noise") is recognized today to be the 
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origin of the miniature endplate potentials (mepps) or quanta (Fatt and Katz, 
1952; Katz, 1962). Miniature endplate potentials have been detected at all 
vertebrate nerve-muscle junctions thus far studied including those at both 
red and white muscles (Fatt and Katz, 1952; Boyd and Martin, 1956a; 
Brooks, 1956; Liley, 1956a; Burke, 1957; Takeuchi, 1959; Elmqvist, Johns 
and Thesleff, 1960). 
It ha.s been found that mepp amplitudes recorded from the same cell 
or from a population of cells show only a small variation about the mean 
with a certain incidence of "giant'; potentials whose amplitude has been 
attributed to be a multiple of the mean (Fatt and Katz, 1952; Liley, 1956a; 
Boyd and Martin, 1956a). The variation about the mean has been suggested 
to be due to differences in the postsynaptic properties of the impaled cell, 
especially the celi diameter (Katz and Thesleff, 1957). Because of this 
stability in amplitude it was then possible to divide evoked synaptic 
potentials (epps) into their proposed component units, namely the mepps 
or quanta. Various methods have been employed to produce such a 
situation, but the most effective involved changing the composition of the 
perfusion solutions by lowering [Ca-'-+], raising l).\1Tg ++ ], or by combining 
these procedures (del Castillo and Engback, 1954). The value of this 
lprocedure will be pointed out lat~r in speaking of detel'mination of the 
. . 
quantal content of epps. 
Changes in mepp amplitude can reflect either a pre- or post-synaptic 
I 
I 
I 
~ -------------·~------..---~2~1~------------------------------. 
action, or both a?tions. Usually a postsynaptic action is the primary cause 
of such an effect. In measuring mepp amplitude one should also inspect 
possible changes in the rise-time, i.e. the time interval between the be-
ginning of the potential and the attainment of its peak amplitude, and in the 
half-decay time, i.e. the time interval between the peak amplitude and the 
decay to 50% of this amplitude. A change in the rise-time of the mepp may 
suggest a difference in the binding properties of the postsynaptic receptor 
to the transmitter or a change in the rate of release; whereas a change in the 
half-fall may indicate a difference in the passive membrane properties of the 
postsynaptic membrane or an anti-A cChE action. 
Drug-induced changes in mepp frequency, on the other hand, are 
usually attributed to a presynaptic action (Katz, 1962). Parameters such 
as temperature changes, osmotic changes within the bathing solution, or 
varying the resting membrane potential can all modify the frequency of 
mepps (Fatt and Katz, 1952; del Castillo and Katz, 1954a; Furshpan, 1956; 
Liley, 1956a; Hubbard et al., 1967; 1968). Ionic balance of the contents of 
the perfusion fluid also aff ccts the normal frequency; the concentration of 
calcium is esp~cially importaat. l\fopp frequency is reduced but not 
abolished in the absence of calcium in the bathing medium, while the 
" production of evoked release of ACh by nerve impulses is completely 
1 abolished (del Castillo and Stark, 1952; Liley, 1956a; Hubbard, 1961; I Hubbard et al., 1968). Although statistically significant changes from , 
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control can be induced by certain drugs, only by elevating external potas-
sium ion concentration is a marked increase of the release obtained. 
Analysis of the mepp frequency leads to a Poisson distribution (Fatt 
and Katz, 1952). A Poisson distribution is obtained when the probab.ility 
of the occurence of an event is constant over appreciable periods of time, 
and the chance of an event occurring. is unaffected whether other similar 
events occur or not (Hubbard, Llinas and Quastel, 1969). Gage and Hubbard . 
(1965) utilized a method for determining that mepps do in fact follow a 
Poisson distribution by applying data to the Poisson Generating Function 
given by the relation: t = 
where tis any interval of time during which 'm', a mean number of 
Poisson events is expected to occur; 'n' is the actual nnmber of events that 
do occur. Another useful indicator that the distribution obtained is indeed , 
. 
i 
I 
Poisson is the equality betyv·een the mean of a series and its variance (cf. 
below, under methods). 
The second type of transmitter release is that due to evoked stimulation· 
' 
resulting from the nerve impulse. The resultant potential recorded at the 
neuromuscular junction has been termed the endplate potential (epp). 
However, in order to record this response one must first eliminate the 
' 
i 
I 
I 
muscle action potential and the muscle contraction. ' This can be accomplish- j 
I 
ed by using pharmacological blocking agents, varying the extracellular ionic 
concentrations, or using .surgical techniques. The epp is a local depolari-
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zation of the motor endplate brought about by the action of ACh. Fatt and 
Katz (1952) have demonstrated that at rest. the recorded membrane 
potential of the endplate does not differ from that recorded elsewhere along 
the muscle membrane. On the other hand, only the endplate area is 
especially sensitive to the action of ACh in the normal muscle. This is 
not the case. however, in chronically denervated muscle, in which the 
entire muscle surface becomes ACh sensitive (Thesleff .. 1960). This 
specific area of the postsynaptic endplate membrane which reacts to ACh, 
i.e. the cholinergic receptor, has most recently been suggested to have a 
molecular weight in the range of 40, 000 and to be proteo-lipid in nature 
(Changeux, Kasai and Lee, 1970; Miledi, Molinoff an:d Potter, 1971; 
and de Robertis, 1971). The interaction of acetylcholine with this 
receptor causes a permeability change in the membrane such that its 
selectively permeable nature to cations is diminished. The resultant 
potential change is unlike that seen in the case of the nerve or muscle 
action potential. but is rather a non-reversing potential that tends towards 
an equilibrium level. This equilibrium level has been reported to be in the 
range of -JO to -20 m V in frog muscle or frog ganglion (Blackman, 
/ 
Gi.nsborg, and Ray, 1963; del Castillo and Katz, 1954; Nishi and KoketSlL 
1960; and Takeuchi and Takeuchi', 1960). The epp also differs from the 
I nerve or muscle· action potentials in that it is graded, rather than "all-or-
lnone" in nature. If this depolarization is great enough and rea_c:~~--,-· 
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threshold level, it initiates a propagated muscle action potential. The 
amount of ACh released to produce this chain of events is usually about 
five-fold in excess of that required; but the excess is easily hydrolyzed so 
that the endplate can become repolarized before the end of the refractory 
period of the muscle fiber. 
The successful production of an epp is inherently involved with the 
mechanism by which ACh is released. A simple definition of increased 
release of transmitter would be facilitation, whereas depression would 
signify a decrease in quanta! release. As mentioned earlier, the release 
of ACh by nerve impulses at the vertebrate nerve-muscle junction is 
impossible in the absence of calcium (del Castillo and Stark, 1952; Liley, 
1956; Harvey and Macintosh, 1940). Hodgkin and Keynes (1957) sugg·ested 
that the depolarization of the squid giant axon by the nerve action potential 
was produced by influx of sodium ions, accompanied by some calcium ions 
and speculated that the calcium ions might lead to synaptic vesicle break-
down and to the release of ACh. They have demonstrated that at rest there 
is very little free calcium ions in the axoplasm, but during activity there is 
a sharp rise in calcium influx. During rest, the calcium ions that have 
entered are slowly pumped out. Evidence for calcium involvement in ~ 
' release was further established since the amount released varied over a 
, 
wide range with the concentration of calcium in the bathing medium (del 
25 
Where and when does calcium affect the release? There is evidence 
that calcium occurs as a bound complex CaX in the ratio of 3 or 4 
molecules to each binding site on the external surface of the terminal 
membrane. This complex is believed to accelerate the release process with 
each nerve action potential (Dodge and Rahaminoff, 1967). Using this model, 
Hubbard et al. (1968) have developed. a kinetic scheme to explain the effects 
of calcium ions and magnesium ions on both spontaneous and evoked release. 
It should be pointed out that the effects of calcium on transmitter release 
as measured. by the increase in quanta! content of the epp cannot be due to a. 
calcium-mediated sensitization of the endplate to ACh, as high calcium does 
not enhance, but depresses the endplate sensitivity to ACh (del Castillo and 
Stark, 1952; Lundberg and Quilisch, 1953; Takeuchi, 1963). 
The most recent proposal for calcium entry into the nerve terminal 
involves cyclic adenosine-3'5'-phosphate (C-AMP) (Rasmussen and 
Tenenhouse, 1968). The reported small increase in mepp frequency induced 
by norepinephrine (Krjnevic and Miledi, 1958; Jenkinson, Stamenovic and 
Whitaker, 1968; and Kuba, 1971) may constitute the evidence linking C-AMP 
I 
I 
I 
I 
I 
with Hie transmitter release at the neuromuscular junction. Indirect evidence'. 
i ;::u.:::~::.:n::~::::e f ~::::~:::r:~:; ::::~::: :::f ::::~::::::· u:::). lj. 
C-AMP analogues. Might it be possible that C··i\11/IP is the compound "X" 
. ·+-+ 
to which 3 or 4 molecules of Ca are attached at the release site? 
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The tin-ie component at which calcium affects the release process was 
limited to the period of 1 to 2 msec during which the increase in the 
concentration of external calcium occurs prior to the invasion of the nerve 
terminal by the nerve action potential (Katz and Miledi, 1965, 1967). These 
data indicate that calcium ions are involved in an essential step between the 
membrane depolarization and ACh r~lease which is not related to the effects 
on the electrical properties of th~ nerve terminal. 
Mathematical Interpretations of Transmitter Release 
There are various methods available for estimating evoked trans-
mitter release. In all cases however, when determining a presynaptic 
release process at the mammalian neuromuscular junction one must base 
the analyses upon results obtained postsynaptically - assuming that the 
postsynaptic potential is an accurate relative assay of transmitter release 
(Bloedel, Gage, Llinas and Quastel, 1966). The three main methods 
employed for determining quanta! content are: 1) The Direct Method; 2) 
The Variance Method; and 3) The Method of Failures (del Castillo and Katz, 
1954; Martin, 1955; Boyd and Martin, 1956; Liley 1956; Dudel and 
I Kuffler, 1961; Kuno, 1964; Elmqvist and Quastel, 1965). Using the var~ance 
method as described by Elmqvist and (::1uastel (1965) the effects of catechol 
' 
upon transmitter synthesis, storage, and mobilization have been analyzed 
in this dissertation. 
r:--------·1 
PHARMACOLOGY 
' 
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There are various mechanisms which have been suggested for the 
actions of drugs at the neuromuscular junction. These can be broadly 
divided into pre- and post-synaptic mechanisms. The presynaptic 
mechanisms include: 1) reduction of transmitter release; 2) prevention of 
transmitter release and 3) increase of transmitter release. The post-
synaptic mechanisms include: 1) motor endplate block; 2) sensitization; 
3) anti-cholinesterase activity and 4) membrane characteristics. 
Presynaptic Mechanisms 
A reduction of transmitter release from the nerve can be accomplished ' 
~ 
most dramatically with a group of compounds known as the hemicholiniums. 
These compounds, originally synthesized by Long and Schueler (1954) have , j 
been demonstrated to have a variety of actions; in lower concentrations, they; 
appear to inactivate specifically the choline-carrier mechanism. This 
system is responsible for the transport of extra-cellular choline across 
the membranes of cholinergic nerve-endings to the intracellular site of its 
action. The paralysis that is produced is delayed in onset, dependent upon 
the frequency of stimulation, and antagonized by choline. Compounds having 
· a similar action have been synthesized and include triethylcholine, which 
" 
can be acetylated in the nerve terminal and release~ as a false transmitter 
(Bowman and Rand, 1961). 
L_ 
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The prevention of transmitter release can be brought about in at 
least three ways. If one modifies the ionic concentration of the bathing 
medium, specifically either decreasing the calcium concentration or 
raising the magnesium concentration or by a combination of these two, one 
can interfere with both evoked as well as spontaneous release. Second, the 
local anesthetics such as procaine have also been demonstrated (Harvey, 
1939) to decrease the amount of ACh released. The problem with procaine or: 
many other compounds is that they have a multiplicity of actions so that 
usually the more prominent action on the motor endplate rather than at the 
nerve terminal is observed (del Castillo and Katz, 1957). The third manner 
in which release can be prevented is with botulinum toxin (Brooks, 1956). 
In nerve-muscle preparations poisoned with this toxin, nerve conduction is 
not affected and the muscle still responds to ACh injected close-arterially; 
but, release of transmitter is prevented. One can also record a decrease in 
the frequency of mepps without a change in their amplitude after application 
of this toxin. 
An increase in the release of transmitter output (facilitation) from the 
nerve can, like its prevention, be brought about in a variety of ways; in 
all cases, the phenomenon most readily noted is the increase in the 
frequency of mepps. Changing lhe ionic concentration of the bathing medium 
[~_:nc~asing the external calcium concentration causes a large increase in ' 
ase of transmitter. Katz and Miledi (1965) and Elmqvist and .Feldman; 
I 
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(1965) applied cakium ions electrophoretically to the frog nerve terminal 
and the rat diaphragm; in either case, a release of transmitter from the 
terminals could be demonstrated. They also noted that lack of calcium had 
no effect upon propagation of the nerve impulse. These results suggest that 
ACh release is determined by intracellular ionized calcium and that the 
calcium is derived from the influx as well as from the variable membrane 
store of bound calcium which is controlled by the membrane potential 
(Karczmar, 1967). 
Increasing extracellular potassium ions (Liley, 1956) also causes an 
increase in transmitter release; this increase had been attributed to the 
accompanied membrane depolarization this procedure produces. 
Certain compounds have been shown to cause a small but statistically 
significant increase in the frequency of mepps (Blaber and Christ, 1967). 
These compounds, eg. edrophonium, neostigmine, etc., have been suggested I 
t to produce their facilitatory action by causing a repetitive firing in the nerve 
terminal, and consequently in the muscle as well (Riker, Roberts, Standaert, 
and Fujimori, 1957). Prior to the report of Blaber and Christ {1967) 
facilitatory activity has been compared with anti-AcChE activity and these 
two have been found to go hand in hand (Kuperman, Gill and Riker, 196U. 
Sodium has also been suggested to be involved with the release of ACh 
I from the terminal (Birks, 1963; Gage and Quastel, 1966; Birks et al., 1968). 
j 
i The significant role for sodium may be that of maintaining the available 
~ 
r 
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store of transmitter (Katz and Miledi, 1967; Blaber, 1970). 
The nerve terminal action of a drug was first proposed long before 
\ 
the ability to measure mepps. Feng (1936) suggested that "a sympathetic 
action occurs only with indirect stimulation which is of the nature of a 
calcium mobilization, at any rate an ionic readjustment." Masland and 
Wigton (1840) and later Feng and Li (1941) described a method for detecting 
the activity of motor nerve terminals in the cat by means of recording the 
antidromic firing in the ventral root. The principle of the method is that 
I 
I 
I 
I 
' 
when a physostigmine-like drug is administered, a post-stimulus repetition 
arises from the motor nerve terminals and can be detected by recording 
from appropriate ventral root filaments. This signals that the drug has 
acted on the nerve endings (Riker and Okamoto .. 1969). Using this technique, 
Werner (1960) proposed a mechanism to explain facilitatory drug action; 
this action causes a potentiation of the isometric contractile response of the 
. 
muscle, stimulated through the nerve, singly and maximally, as well as 
constitutes the basis of anti- curare and anti-myasthenic activity (Riker and 
Standaert, 1966). ·werner (1860) postulated that facilitatory drugs enhance 
the capacity of the unmyelinated terminal to interact with the main axon. 
The following year Werner (1961) demonstrated that ephaptic transmission 
. 
was not involved in facilitatory a~tion and that an antidromically propagated 
action potential did originate in the nerve terminal. Riker and Standaert 
________ ____.,,_, __ """"" ____ ..._ ______ .._. ________________________________________ _, 
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augmentation of t,he negative afterpotential in the unmyelinated segment of the 
axon, at a point close to the myelinated portion which caused a triggering of I 
I the generation for post-tetanic repetition. The initial studies using drugs 
that led to this kind of an idea for facilitation were those of Riker and V.f escoe ! 
l 
I (1946) who demonstrated that neostigmine can directly depolarize neuromusc- j 
ular junctions causing excitation independent of cholinesterase action. In 
developing these concepts Riker used derivatives of neostigmine, 3-hydroxy 
P'l'MA (phenyltrimethylammonium) and 3-hydroxy PTEA (phenyltriethyl-
ammonium), which were able to produce twitch potentiation, an anti-curare 
effect and very little anti-cholinesterase action; they <Jid not cause con-
tractions, fasciculations, or neuromuscular blockade (Riker and Okamoto, 
1969). Koelle (1962) has suggested that acetylcholine might act to cause 
facilitation of the nerve terminal after an anti-cholinesterase had been used 
to prolong its half-life. Hubbard (1965) and Blaber and Christ (1967) found 
however that ACh did not increase the frequency of mepps. In other studies_. 
Ciani and Edwards (1963), Martin and Pilar (1963) and Riker (1966) have 
determined in various ways that ACh depresses rather than facilitates motor 
nerve terminal function. Thus, the amount of ACh released is mainly 
dependent upon the degree of depolarization produced by the nerve action 
" potential as it invades the terminal; it does not depend on the ACh which 
may be present in the synaptic cleft. The resting potential of the terminal 
ttherefore determines the size of the presynaptic potential as well as the 
t....,_._,, ______ "" ..... ----,.---·--·"""''~·-" ___ _..., .. ,..... ..... ~"'"---·.-----...... ··-·~~--·-"-''" 
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resultant epp (Hubbard and Willis, 1962a, b). In fact, by hyperpolarizing the 
presynaptic membrane one can cause an enhanced release of ACh. Hubbard 
(1970) concluded that Riker's hypothesis of junctional transmission should 
be abondoned since no local potentials have been detected within motor 
nerve terminals. 
It has been suggested that the depolarizing compounds, succinylcholine 
and decamethonium, may act at the first node of Ranvier to cause a lowering 
of the stimulation threshold. The ensueing potentials are then able to propa-
1 
gate more easily into the nerve terminal (Hubbard, Schmidt and Yokata, 1965; 
Blaber and Goode, 1968). This facilitatory action of tpe depolarizers is 
however, quite dose dependent, since a slightly higher dose of the compound I 
:~:g::::d1:o d::r:::i:; ~:d~~~t::~e ~:~:::::;:i~e 8:::e:f a:ct::nn:::o:::cular l 
junction by Blaber and Karczmar (1967). They suggest five possible sites, I 
three of which are involved in transmitter release. All of these have been I 
already mentioned but a brief enumeration of the three sites may be in order. ; 
First, a choline carrier site is present within the terminal. Second, the 
motor nerve terminal is the site for production of antidromic discharges in 
I 
the motor nerve following orthodromic stimulation associated with facilitation i 
of transmission. Third, the n~otor nerve terminal has another site at the I 
II first node where depolarization may be also associated with facilitation. l I j," l=~~=rs carc:~=~==.~~~-:.=~=~::e_::~=~-·.I 
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in some degree at all other sites and may act as an agonist at some sites l 
and as an antagonist at others". 
While subsequently more sites of pre- as well as of post-synaptic 
action were more recently suggested in this laboratory (Karczmar, 1967b; 
Karczmar et al., 1970; Karczmar and Nishi, 1971), I am interested in at 
least one additional pre- and post-synaptic site that may be adrenoceptive in 
nature. 
Presynaptic Adrenoceptive Site 
In 1967, after many previous papers relating to the subject (cf. 
Bowman and Raper, 1966) Bowman suggested that at the neuromuscular 
junction there may be adrenot::.~opic receptors which can be classified 
according to the subheadings of alpha and beta after Ahlquist (1948). The 
alpha-receptors appeared to be present in the motor nerve endings and 
their activation would facilitate neuromuscular transmission by increasing 
the release of transmitter by nerve impulses. The beta-receptors appeared 
! to be present in skeletal muscle fibers and their activation will either cause 
i 
a facilitation or dE-p:cession of the muscle contraction. 
The first report of a facilitatory action by the sympathomimetic 
amines vrns by Par.,ella (1907) as he demonstrated that epinephrine had an 
• 
anti-cur:-1re effect. Bowman and Nott (1969) have reviewed the literature I 
i 
listing confirmations of this anti-curare action .in the amphibian, mammalian,; 
! 
l 
and avian muscle. The clnracteristics of this particular anti-curare action j 
r.--35 __ __, 
suggest that it is mediated through alpha-adrenoreceptors, as it is produced 
by epinephrine and to slightly lesser extent by norepinephrine while 
isoproterenol is ineffective. Furthermore, the anti-curare effect is blocked 
by the alpha-receptor blocking drugs (Maddock, Rankin and Youmans, 1948) 
but not by the beta-receptor blocking drugs (Bowman and Raper, 1966). 
It has been demonstrated that epinephrine and norepinephrine exert a 
presynaptic action since each increases the amplitude of epps produced by 
motor nerve stimulation in both frog and rat muscle when neuromuscular 
transmission was depressed by curare or by elevating the concentration of 
. magnesium ion (Hutter and Loewenstein, 1955; Krnjevic and Miledi, 1958; 
Jenkinson, Stamenovic and Whitaker, 1968; Kuba, 1970). Kuba demonstrated 
that norepinephrine did not affect the amplitude of iontophoretically applied 
ACh, while both epinephrine and isoproterenol increased this response. All 
of the authors were able to demonstrate an increase in the frequency of 
mepps only by the compounds classified as alpha-receptor stimulants. On 
the other hand, norepinephrine did not increase the amplitude of the mepps 
while the compounds possessing beta-receptor stimulant activity did. 
Jenkinson, et al. (1968) have demonstrated that the increase in amplitude 
of epps produced by norepinephrine in frog muscle was blocked by 
phentolamine but not by proprahalol. 
A prejunctional action of epinephrine is supported by the observation 
that during the epinephrine-induced increase of the partially curare-blocked 
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contractions evoked by motor nerve stimulation, COI\tractions produced by 
close-arterially injected ACh and the endplate depolarizations produced by 
succinylcholine were slightly inhibited (Bowman and Raper, 1966). 
Indirect evidence suggests that the increase of ACh release produced 
by epinephrine is the result of a hyperpolarizing action on the motor nerve 
ending (Krnj evic and Mile di, 19 58). Epinephrine also ca us es hyperpolari -
zation of isolated mammalian "C" fibers (Goffart and Holmes, 1962). 
Other evidence that epinephrine may in general cause hyperpolarization of 
nervous tissues comes fro1n the experiments of deGroat and Volle (1965) who 
showed that epinephrine increased the demarcation potential of ganglion 
cells. This postsynaptic hyperpolarizing action depresses ganglionic 
transmission, but, like the anti-curare action of epinephrine, it is inhibited 
by the alpha-receptor blocking agents. It may be possible that epinephrine 
acts at the first node of Ranvier (Bowman and Nott, 1969) to cause 
hyperpolarization. 
Another facilitatory action of epinephrine is demonstrated by its 
ability to potentiate the twitch augmentation and repetitive firing in both 
nerve and muscle produced by the anticholinesteras': or the depolarizing drugE 
(Bulbring and Burn, 1942; Blaber and Bowman, 1963; Bowman and Raper, 
1966). Bowman and Raper's r~sults had demonstrated further that alpha-
receptor blocking drugs prevent this potentiation which they classified as 
being mediated through alpha-receptors. In contrast to the results of 
..._ ______________________ _ 
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Bowman and Raper, Breckenridge et al. (1967) demonstrated that the 
' 
potentiation of neostigmine by epinephrine was blocked by propranalol, a 
beta-receptor blocking drug, and concluded that this effect was therefore 
mediated through beta-receptors. 
In this same study, Breckenridge et al. (1967) pointed out that 
epinephrine stimulated the formation of adenosine-3', 5'-phosphate (C_-AMP) 
within many tissues. This action of epinephrine on C-AMP has been 
thoroughly investigated by Sutherland and Robison (1966). Breckenridge 
et al. (1967) also indicated that C-AMP levels can be raised with theophylline, 
which inhibits hydrolysis of the nucleotide by a phosphodiesterase. From 
their results they concluded that the effects of epinephrine either at the 
nerve terminal or the muscle may be mediated by C-AMP; and that this 
mediation is via beta-receptor interactions. 
There are many other possible mechanisms of action at the nerve 
terminal or other explanations for the mechanisms thus far proposed. 
However, I should like to leave the nerve terminal and begin to describe 
some of the concepis that have been proposed for postsynaptic mechanisms. 
Postsynaptic Mech;misms 
In 1851, Claude Bernard published his classical experiments on the site 
' 
of action of curare in the frog. In 1935, King isolated D-tubocurarine from 
curare and this stimulated a greater interest into the mode of action of 
neuromuscular blocking agents and resulted in major advances concerning .__.. ____________ .._.._. _______ , ________________________________________ .._. ____ __ 
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the physiological processes underlying the transmission of the excitation 
wave from motor-nerve endings to voluntary muscle .. The mechanism by 
which curare produces its motor endplate block is generally described as 
an. interference with the action of A Ch at the motor endplate so that a 
muscle contraction is only elicited by a quantity of ACh greater than normal 
{Bowman, 1962). Curare prevents the response of skeletal muscle to motor 
nerve impulses and to injected ACh; during the paralysis, nervous conduction 
continues and the muscle fibers themselves retain their sensitivity to 
direct stimulation. Paralysis can be maintained with curare; throughout 
this paralysis a.s well as at its height, the output of ACh is not significantly 
altered (Dale, Feldberg and Vogt. 1936). Similarly, Martin (1955) and 
Beranek and Vyskocil {1967) have not shown any significant reduction 
of the quantal content of an epp in the presence of curare. On the other hand, 
Hubbard, Wilson and Miyamoto {1969) have demonstrated using the cut fiber 
technique that curare decreases tho/' quanta! content, readily releasable 
stores, and mobilization while increasing the probability of release at the 
rat diaphragm phrenic-ne:r;ve preparation. Auerbach and Betz (1971) using 
the voltage clamp technique were unable to demonst::ate a significant decrease 
in the quantal content and attributed the results of Hubbard et al. (1969) to a 
technical problem of electrode positioning. It was concluded by these authors 
that if curare affected transmitter release at all, its effects must be much 
smaller than its well-known postsynaptic action. 
~-----39 -----. 
A second mechanism involved with postsynaptif action is that of the 
depolarizing drugs. In general, these compounds produce an electrical 
inexcitability, arising as a result of a prolonged depolarization in the region 
of the motor endplate (Bowman, 1962). A Ch in high concentrations has long 
been shown to produce neuromuscular block (Bacq and Brown, 1937). Due 
to its rapid hydrolysis by AcChE, ACh is not a useful blocking agent unless 
in the presence of anti-AcChE drugs; but in essence all of the depolarizing 
blockers act via this mechanism. The ~ost active members of this group 
are decamethonium and succinylcholine, differing basically in their duration 
of action. Both compounds had originally, like curare, been assigned only a 
postsynaptic mode of action, but actions on the nerve terminal possibly 
explaining their initial facilitatory response have been proposed (Blab er and 
Karczmar, 1967a, b). Depending upon the animal species these agents in 
the process of their blocking action increase the threshold of ACh resulting 
in a "dual mode of action" block (Zaimis, 1953; Thesleff, 1955). This second 
postsynaptic process which appears to follow the initial depolarization and 
is inherent to the blocking action is a phenomenon termed "desensitization". 
This action differs from the competitive blockade seen with curare-like 
compounds since it is non-competitive and responds poorly to high concen-
trations of acetylcholine or to :!nticholinesterases (Karczmar, 196'7; Kim 
• 
and Ka:::·czmar, 1967). 
A postsynaptic facilitatory action may be realized with the anti-ChE 
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agents. These compounds act to increase the amplitude of the twitch 
' 
response resulting from indirect stimulation as well as to antagonize curare 
blockade by augmenting and prolonging the intracellularly recorded epp. The 
extent to which these compounds exert their pharmacological actions by 
inhibiting AcChE or ChEs generally is a subject of many investigations 
(Karczmar, 1967a and b). These agents have been used in the treatment of 
myasthenia gravis. Their successful history in certain cases is 
still due more to the art rather than the science of medicine (Thesleff and 
Quastel, 1965). 
Postsynaptic Adrenoceptive Site 
As stated earlier catecholamines have been demonstrated to have a 
presynaptic facilitatory action. These agents also possess a direct post-
synaptic action. Epinephrine increases the contractions of non-fatigued 
fast contracting muscle when the stimulation is applied directly after full 
curarization or chronic denervation (Bowman and Zaimis, 1958). This 
action has been suggested to be due to the activation of the beta-receptor 
since among the catecholamines tested L-isoproterenol is the most potent. 
An interesting anomaly is that slow contracting musCles respond to 
sympathomimetic amines by depression rather than facilitation. It has been 
" 
demonstrated that maximal isometric twitch tension, whether evoked by 
nerve stimulation or by direct stimulation of the fully curarized or by direct 
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stimulation of the chronically denervated muscle, is.reduced by up to 20% 
(Bowman, Goldberg and Raper, 1962). It should also be noted that the 
sensitivity in response to catecholamines is much greater in the slow 
muscles than in fast muscles. 
Another postsynaptic facilitatory action has been proposed which is 
different from this ''pure" beta-receptor activation. Gruber (1914) was the 
first to suggest that the effects of epinephrine on muscle contractions may 
be secondary to the activation of the carbohydrate metabolism. Epinephrine 
and other catecholamines exert a pronounced stimulant effect on glyco-
genolysis in tissues (Cori, 1931). Epinephrine also stimulates the adenyl 
cyclase system, and it has been further suggested that adenyl cyclase 
may actually constitute the receptor for epinephrine (Robison, Butcher and 
Sutherland, 1967). Adenyl cyclase in turn catalyzes the conversion of 
adenosine triphosphate (ATP) to C-AMP; this reaction has been demonstrated 
to be increased by epinephrine in skeletal muscle (Posner, Stern, and Krebs, 
1965). The cellular content of glucose-6-phosphate in skeletal muscle has 
also been shown to increase in the presence of epinephrine (Belford and 
Feinleib, 1964). Another group of enzymes stimulat~d by epinephrine in the 
presence of calcium ions are the phosphorylases (Ellis and Vincent, 1966). 
Bowman and Nott (1969) list the"literature that gives supporti:ig evidence to 
the concept that the effect of catecholamines on muscle glycogenolysis, like 
the aforementioned effect on non-fatigued muscle, is mediated via beta-
~----4~2 ------. 
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receptors. From this literature the reviewers propose that the production 
of C-A MP may be a common intermediate in the action of epinephrine on 
carbohydrate metabolism and on muscle contractility. They are careful to 
point out however that there is no evidence to support the concept that 
production of C-AMP is the final common step in the two processes, or that 
phosphorylase activation and increased cellular hexosephosphate levels are 
related as originally suggested by Ellis (1959). 
Comparable biochemical studies involving these enzymes (adenyl. 
cyclase, phosphorylase, etc.) and products (glucose-6-phosphate, cyclic-
AMP, etc.) have not been reported using catechol. 
Myasthenia Gravis and Facilitation 
Myasthenia gravis is a disease involving a great weakness of the 
skeletal muscles. In a myasthenic this weakness becomes exacerbated with 
exercise. The first success.ful therapy of this disease was that of Remen 
(1932) and Walker (1935) using the anti-ChE neostigmine. There are several 
theories as to the etiology of the disease, but it is generally agreed that there 
may be different varieties of the disease rather than one unique illness. 
One of the possible causes of the disease is an· inability for a sufficient 
amount of transmitter to react with the postsyna.ptic receptor. Two general 
views have been proposed with regard to this lack: 1) there may be a 
desensitization of the endplate to the normal amount of released ACh (Grob, 
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Johns and Harvey, 1956); or 2) there may be a normally responsive endplate 
but less transmitter is being released (Desmedt, 1957). The success of 
anti-ChE therapy can readily be understood if one holds either of these views. 
However, on more than one occasion the myasthenic will either gradually 
develop a refractoriness to these agents or else be refractory to them from 
the very beginning. Another view that has been proposed is that the disease 
may have an autoimmune etiology and that the proper therapy would include 
immunosuppressive agents (Wolf et al. , 1966). A possibility which I feel 
deserves more attention is employing agents that might facilitate transmitter 
release. Lower doses of anti-ChEs have been shown to have a direct 
presynaptic facilitatory effect (Blaber and Christ, 1967). Possibly the 
combination of these agents with sympathomimetic amines might prove to be 
an effective tool if there is a deficiency of transmitter. 
History of Catechol 
Catechol has had several synonyms through its course of study. The 
original German papers referred to it as "Brenzcatechin" or "Dioxybei:zole". 
More recently it has been ref erred to as pyrocatechin, pyrocatechol, and 
finally simply catechol. Chemically, it is a dihydroxy substituted benzene 
with the two hydroxy substituent groups in ortho- position to each other; 
' 
catechol is then l, 2-dihydroxybenzene (Fig. 2). Catechol is classified as a 
derivative of phenol (Fig. 4) which possesses most of its chemical properties. 
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Pharmacologically it is classified as the basic nucleus of the sympatho-
mimetic amines. Bacq (1949) stated that the two phenolic groups of epine-
phrine are essential to the determination of the quality and intensity of 
sympathomimetic action of aromatic amines. He further concludes that the 
hydroxy group of epinephrine in the meta- position is more important than the 
hydroxy group in the para- position and, finally. that only catechol 
derivatives may be considered to be true sympathomimetic amines. 
Catechol has not had any medicinal value as such·. but some of its 
derivatives. eg. guaicol, guaicol carbonate and eugenol. as well as its 
mono-hydroxy parent compound. phenol, have been recognized as having 
medicinal uses. Phenol is one of the oldest antiseptics. having been 
introduced into surgery by Sir Joseph Lister in 1867. In addition to its 
bactericidal activity, which is not very strong, it has a caustic and slight 
anesthetic action. The bactericidal activity of most substances has been 
compared to phenol as a standard. and this activity is reported as the 
phenol coefficient. High concentrations of phenol will precipitate proteins, 
whereas low concentrations denature proteins without coagulating them·. 
This denaturing activity does not firmly bind phenol and as a result it is 
able to penetrate the tissues. The action on tissues is a toxic one; pure 
phenol is corrosive to the skin. 'I' destroying much tissue, and may cause 
gangrene. As a rule phenols are inactive as bactericidal agents in the 
presence of serum. possibly because they combine with serum albumin, 
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and thus are not free to act upon the bacteria (Wilso~ and Gisvold, 1962). 
Clinically, phenol has been used via injection to cause nerve blocks in 
cases of spasticity or else via intrathecal injection for the relief of intrac-
table pain. There are two possible explanations for its success in reducing 
spasticity. It may act by inhibiting the thin motor neuron fibers of the 
\ 
muscle efferents (gamma fibers) which adjust tone to various muscle 
lengths without inhibiting the larger alpha fibers that innervate striated 
muscle, causing a decreased reflex activity and therefore reducing spasticity. 
. I 
A second possibility is that phenol may block or partially block a percentage 
of nerves regardless of size (Talbott, 1965). 
The metabolism of catechol or phenol is primarily via oxidation. 
Within the body catechol (a metabolite of phenol) is metabolized via four 
main pathways. 1) It is excreted as such in the urine; hydrolyzed human 
urine contains 5mg free catechol per liter whereas none is seen in 
unhydrolyzed urine (vonEuler and Lisbayko, 1959). Fiker (1955) points out 
that in the case of the workers exposed to benzene vapors their urine con-
tains up to 100 mg/ L. 2) Catechol can be oxidized to hydroquinone or 
hydroxyquinone. Hydroxyquinones can be further o~dized by either the 
cytochrome oxidase system or polyphenoloxidase. The resultant oxidized 
products are able to inhibit amfoe oxidase (Friedenwald and Hermann, 1942). 
3) About 18% of the measurable metabolite has been identified as a conjugated 
product with sulfates to form mono-sulfuric acid esters. 4) The final and 
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most common mechanism, amounting to up to 70%, is a conjugation of 
catechol with glucuronic acid to form the monoglucuronide. It has been 
demonstrated that in the rabbit about 70% of orally administered catechol is 
excreted in one of these forms within twenty-four hours. 
Many plant phenolics have been demonstrated to sensitize smooth 
muscle to epinephrine. A possible mechanism has been suggested which is 
the inhibition of the enzyme methyl transferase (Axelrod and Tomchik, 1958; 
LaBrosse, Axelrod, and Key, 1958). These authors have further demon-
strated that epinephrine in vivo is inactivated by o -methyl transf erase which 
methylated the phenolic hydroxyl group of epinephrine in the 3-position. 
Epinephrine however is not a specific substrate; other diphenols are also 
methylated by this enzyme. Therefore, catechol might act to sensitize 
the smooth muscle in vivo by competitive inhibition of the methyl 
transferase. From these experiments and the fact that in vivo iproniazid or 
any inhibitor of amine oxidase does not sensitize to epinephrine, the authors 
argued that methyl transferase is the enzyme which normally inactivates the 
bulk of the catecholamines in mammals. In the following year, Bacq (1959) 
determined that equimolar amounts of catechol inhiqited the inactivation of 
epinephrine via inhibition in vitro of 50% of the o-methyl-transferase. He 
also suggested that this inhibitibn was probably responsible for the 
sensitization of smooth muscle to epinephrine by various ortho - , di-, or tri-
phenols. Later Wylie, Archer, and Arnold (1960) in their study of various 
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polyhydroxyphenols determined that catechol at a do~e of 5x10- 4M was the 
least effective of the substances tested in inhibiting catechol-o-methyl 
transferase. Nevertheless, they suggested that polyhydroxyphenols are 
metabolized by methylation at the 3-position as is epinephrine, and as a 
result there is a competition resulting in a reduced methylation of 
epinephrine as the polyhydroxy phenols act as competitive substrates for the 
enzyme system. This is in agreement with the fact that the phenols 
augment the toxicity of the amines as this may be due to the phenol-induced 
increase in the life span of epinephrine. 
The actions of phenolic derivatives, specifically catechol have been 
studied pharmacologically - the brain, the heart, the peripheral circulation, 
rabbit duodenum, guinea pig ileum, uterus, pupil, blood sugar, and 
skeletal muscle. 
Catechol has been suggested to act as a convulsant which differs from 
other convulsants (namely, metrazol, strychnine, caffeine, and picrotoxin) 
having an anatomic site of action at the globus pallidus (Matsumoto et al. , 
1963; Matsumoto and Nishi, 1963a, b). A subconvulsive dose of catechol 
increased the fast components in the EEG of the globus pallidus and DOPA 
(lOmg/kg, i. v.) decreased these components in this part. Norepinephrine, 
epinephrine, thiopental, and ch'forpromazine augmented the catechol induced 
convulsion while pentobarbital was anti-convulsive. Reserpine had two 
different effects upon the catechol convulsion: 1) the convulsion was 
48 
suppressed in rats or rabbits pretreated with reserpine (lOmg/kg) 30 minutes 
prior to catechol injection (0. lM, 3ml/kg, S. C. ); 2) four and 24 hours after 
pre-treatment with reserpine the convulsion was augmented. The catechol 
convulsion was markedly suppressed 30 minutes after the administration of 
DOPA (150mg/kg, I. P.) or five minutes after the injection of dopamine 
(20µg/kg, i. v. ). The augmentative action by reserpine of the catechol 
convulsion was inhibited by pretreatment of DOPA, and this suppressive 
action was antagonized by norepinephrine. Because of this these authors 
suggested that one of the augmentation-suppression mechanisms of the 
catechol convulsion depended on the relative relatiOnship between norepine-
phrine and dopamine contents in the animal brain. 
White and co-workers (1965) studied various drugs, including catechol 
with respect to reticular potentials evoked by peripheral stimulation and 
with respect to the rabbit EEG. Catechol (6-12mg/kg, i.v.) was similar to 
physostigmine (O. lmg/kg, i. v.) in abolishing midbrain reticular evoked 
responses and inducing EEG activation. The effect on the reticular evoked 
potentials lasted 4-16 minutes and recovery took 3-9 minutes, the EEG effect 
outlasting the abolition of the reticular response. Conduction was not 
impaired by these compounds. Attempts to block this effect of catechol 
with either phenoxybenzamine, 'l>entobarbital, or scopolamine were 
unsuccessful, whereas scopolamine or atropine blocked both of the electro-
physiological actions of physostigmine. Finally, catechol abolished or 
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markedly reduced a cortical evoked response and this block was not prevented 
~ by either phenoxybenzamine or imipramine. 
( 
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Rogers, Angel and Butterfield (1968) have studied the effects of cate-
chol (60mg/kg, I. P.) following its penetration into the mouse brain upon 
cerebral monoamine levels. They showed that catechol elicited convulsions 
consisting of jerks and tremors within 15-20 sec, with peak convulsive 
activity occurring after 2-3min and a duration of 8 min. They were unable 
to determine any changes in brain levels of either dopamine, norepinephrine, 
or 5-hydroxytryptamine. 
A central component responsible for the circulatory stimulant actions 
of catechol was proposed by Gotgounis and· Walton (1958) using isolated 
heart and papillary muscle. Walton, Walton and Thompson (1959) using 
mongrel dogs anesthetized with barbiturates studied the positive inotropic 
effects of various phenolic derivatives in situ. All drugs were administered 
intravenously, and DOPA (20mg/kg), catechol (100-300 mg/kg) an:d phenol 
(100-575 mg/kg) produced various degrees of positive inotropism. All 
benzenediols produced cerebral awakening effects and evidence of 
sympathetic stimulation appeared as pilomotor effects. There was an 
apparent dual action of the benzenediols, appearing immediately as cardiac 
If 
depression followed and antagonized by a stimulant component which became 
greater after initial "sensitizing" doses. This "sensitizing" effect was least 
prominent with catechol. Phenol induced only a depressant inotropic effect, 
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and skeletal muscle spasms. It was noted that responses to norepinephrine 
were diminished after large doses of the benzenediols.· Also DOPA 
produced no skeletal muscle effects, but cerebral awakening effects were 
noted; dopamine, 25µg/kg, exhibited marked inotropic and depressor potency. 
As early as in 1896 Muhlmann reported that catechol caused an increase 
in blood pressure when injected into the anesthetized rabbit. Dakin (1905) 
injected lOmg of catechol into a 2. 2 kg rabbit and produced a great increase 
in blood pressure. He suggested that the two free hydroxy groups in the 
nucleus are essential constituents of active substances, since of the three 
isomerid dihydroxybenzenes tested only catechol produced a rise in the 
blood pressure after injection; he also felt that the hydroxy groups must 
be in the ortho- position in relation to one another. Barger and Dale (1910) 
concluded that catechol raised blood pressure through a peripheral action 
rather than via the vasomotor center since they used decapitated cats. They 
also suggested that the mechanism consisted not of a sympathomimetic 
action but depended on a direct action on the smooth muscle. Harold, 
Nierenstein and Roaf (1911) showed that phenol, in small doses caused a 
slight rise in blood pressure accompanied with muscular tremors which 
they thought were induced as a ~irect action of the drug since the animals 
were curarized and decapitated. In the same study, catechol caused a 
marked vasoconstriction at dose of 0. OlGm, with a smaller effect at 0. 03Gm, 
' 
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while at 0. 3Gm a sudden permanent stoppage of the heart was observed. 
Also noted wel'.'e a darkening of the blood with each injection accompanied by 
muscular twitching as the heart beat became irregular and missed beats 
occasionally. Tainter (1930) using cats concluded that results with catechol 
regarding pressor and pulse rate effects showed no correlation between 
dose and type of circulatory response. He did observe that injections of 
catechol were uniformly accompanied by increases in the activity of 
skeletal muscles and most commonly be severe tremors and convulsions. He 
attempted to control these side effects by giving curare to the point at which 
the diaphragm was 100% paralyzed. His results indicated that catechol was 
causing convulsions which were partly of central and partly of muscle origin. 
He also agreed with Barger and Dale (1910) that catechol had direct and 
apparently general muscular stimulating action on smooth muscle organs. 
When pretreating the cats with cocaine, he saw variable effects with catechol, 
altogether some sympathetic stimulation was generally present. After 
ergota.mine, he did observe some reversal of stimulation in the majority of 
cases. In analyzing catechoPs effects upon the heart he always saw 
depression and cardiac dilation. A report by Mulinos and Osborne (1935a) 
compared the effects of catechol and epinephrine on blood pressure in 
" anesthetized cats. Catechol and epinephrine produced similar effects 
causing an elevation of blood pressure when the cord was intact, in a pithed 
cat, or after pretreatment with cocaine. The only instance of a difference 
™-·-
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t between epinephrine and catechol was noted after pretreatment with ergot-
, 
amine. In this case, there was a reversal of the epinephrine effect, i.e. 
vasodilation, whereas catechol still ii1duced some vasoconstriction. 
The same workers (Mulinos and Osborne, 1935b) compared the effects 
of catechol, epinephrine and ephedrine on the uterus of the cat. In the virgin 
preparation the three compounds behaved similarly, differing only in the 
degree of relaxation. These results were opposed to those of Barger and 
Dale (1910) who stated that catechol did cause a contraction of the isolated 
virgin uterus; a point they used to substantiate a direct muscle stimulating 
action for this compound. In the hands of Mulinos and Osborne epinephrine 
only caused a contraction of the pregnant cat uterus while catechol and 
ephedrine caused relaxation. These same effects were also demonstrated 
using the pregnant rabbit uterus. These authors then investigated the 
small intestine of either the cat, rabbit, or monkey showing that catechol 
acted as did epinephrine to cause relaxation and a contraction. Catechol 
diffe:red from both epinephrine and ephedrine in not causing a dilatation of the 
pupil in either the cat or rabbit. This absence of pupillary action was also 
reported by Barger and Dale in their 1910 paper. Furthermore, Mulinos 
and Osborne (1935b) examined fhe ergotamine-catechol interplay and showed 
that none of the effects of catechol could be reversed after pretreatment with 
this alkaloid. 
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"·' ~~ The earliest report on the effects of catechol on the blood sugar 
is that of Dubin, Corbett, and Freedman (1925) who injected lmg/kg into a 
rabbit and concluded that it was ineffective in reducing blood sugar levels.· 
At a dose of 150 mg/kg the rabbit initially went into tremors as seen in 
phenol poisoning and after 35 minutes died with a massive cardiac hemmor-
rhage. Ten years later, Mulinos and Osborne (1935a) reported that, like 
epinephrine and ephedrine, catechol in the rabbit raised blood sugar levels. 
Sjostrand (19 60, 19 61) reported the effects of catechol on the guinea 
pig ileum. Generally, he saw a stimulation with a dosage range of O. 5-5mg, 
as well as tachyphylaxis. He compared the stimulatory effect of 2mg of 
catechol with 2 units of substance P and 0. 005µg of ACh. The contractions 
induced by eithe.r A Ch or catechol were equally abolished by atropine (1: 2 
million). In higher doses, 5-10 mg, catechol had a depressant action and 
blocked contractions induced by ACh, histamine or substance P. From 
these results the author concluded that catechol stimulated the intestine 
through liberation of ACh and that this liberation was mediated by ganglia 
in the walls of the intestine. Furthermore, cocaine (10-50µg/ml) inhibited 
the contraction due to catechol as well as to nicotine (5-20µg) and 
serotonin (O. 05-5µg), while the'effects of histamine, acetylcholine, or 
substance P remained unaltered or augmented (Sjostrand, 1961). Hexa-
methonium blocked the effects of catechol and of nicotine. In sub-effective 
_____ ............., ______________________________________________ ...., ______________ _ 
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1 doses, 10-50µg, catechol reduced the inhibitory acti9n of epinephrine or 
norepinephrine (l-5µg) upon contractions caused by ACh, histamine, or 
sbustance P. When catechol was added to the bath together with either 
epinephrine or norepinephrine an increase in the basal tone of the intestinal 
strip was sometimes seen. On the other hand, Johnson (1962) was unable 
\ 
to stimulate the guinea pig ileum in doses of O. 1-5. O mg. At a dose of 
-4 
5xl0 M, catechol acted as a spasmolytic; it reduced the contractures caused 
by 5-hydroxytryptamine and dimethylpyrophosphate. He compared this 
latter action to the non-specific spasmolytic effect of papaverine. In the 
most recent study, Takagi and Takayanagi {1965) concluded that in the case 
of the guinea pig ileum, phenol caused a decrease in the release of ACh 
whereas in that of the frog rectus abdominis muscle the same concentration 
caused an increased release of ACh. They suggested that there were there-
fore two possible mechanisms for release of ACh; one at the smooth muscle 
effector site and the other at the skeletal muscle. 
The facilitatory action of catechol on skeletal muscle was first 
described by Rothberger (1905); he administered catechol to a curarized cat. 
In his series of experiments he also examined such compounds as nicotine, 
guanidine, veratrine, cresol, 1',yrogallol, and tetraethylammonium, noting 
that all had some degree of anti-curare activity. No other in vivo studies 
---
aimed at determining the mechanism of action of catechol on skeletal muscle 
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,, have been reported since these early investigations and the incomplete 
observations of- Tainter (1930) and Barger and Dale (19~0). There have been 
a few studies concerned with catechol's action on skeletal muscle in vitro. 
Mizuno (1933) and Coppee (1943) used isolated non-mammalian tissue (the 
frog sartorius). 
Mogey and Young (1949) were the first to report on the action of 
catechol and phenol in isolated mammalian tissue, the rat diaphragm. 
The main conclusions of these authors were that phenolic substances 
(phenol, catechol, etc.) do not produce their anti-curare effect by 
cholinesterase inhibition or alteration of pH. They further suggested that 
this antagonism is not due to a chemical combination of antagonist with 
agonist; the mechanism was not elucidated further. Hobbiger (19 52) agreed 
that phenolic substances do not act by cholinesterase inhibition when he 
demonstrated their action on the rat diaphragm after the inhibition of its 
cholinesterase activity with diisopropylfluorophosphate (DFP). Otsuka and 
Nonomura (1962) using the frog sartorius mu~cle attempted to clarify 
whether phenolic substances' facilitatory action was due to either an 
augmentation of the quantity of ACh released from motor nerve endings or 
else an increased sensitivity of the endplate to the transmitter. Their 
results showed that in a curari~ed nerve-muscle preparation phenolic sub-
stances would greatly increase the size of the intracellularly recorded epp 
without altering the sensitivity of the endplate to ACh. This latter conclusion 
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was based upon the fact that although the amplitude of the individual epps 
were enhanced by the compounds, no change was produced in the amplitude 
of potentials induced by iontophoretically applied ACh. The authors also 
suggested that phenolics might not change the amount of the stores available 
for transmitter release in the nerve terminals even though they do increase 
the amount of transmitter released. This suggestion was drawn from the 
experiments of Otsuka and Endo (1960a, b) wherein they concluded that the 
drug-induced depression of the response to the second of double stimuli 
in a calcium rich solution was probably due to the partial depletion of the 
store of available transmitter. The most recent report of junctional phenolic 
action is that of Kuba (1969) who used the slow muscle of the fish. This 
study is the first one in which the effects of phenolic compounds on 
spontaneously released transmitter, i.e. on the mepps, was evaluated; 
their possible effects on the passive membrane properties of the muscle 
were also investigated. His results showed that phenol increased the 
frequency of mepps without changing their amplitude, but did not alter the 
passive membrane properties such as input resistance or time constant. 
From these results Kuba noted the similarity in action of phenol to that of 
noradrenaline (Jenkinson et al., 1968), adrenaline (Krnjevic and Miledi, 
1958), and guanidine (Otsuka anti Endo, 1960), since all of them caused an 
increase in the release of transmitter expressed as an increased frequency 
of mepps. 
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In an effort to resolve some of the controversif-1 results thus far 
reported, this dissertation will analyze the mechanism and site of action of 
the basic structural moieties of the sympathomimetic amines, namely, 
catechol and phenol at the mammalian neuromuscular junction. The data 
may have a bearing on the adjuvant action of sympathomimetic amines 
in myasthenics treated with anti-cholinesterases. 
Future Investigations 
Future investigations will include a similar analysis of the actions 
of ephedrine and ethanolamine at the neuromuscular junction. These two 
compounds should provide some additional information as to the nature of 
adrenoreceptors at the neuromuscular junction. 
rr-------, 
METHODS. 
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Both in vivo and in vitro techniques utilized mqngrel cats of either 
sex weighing between 1. 5-5. 0 kg. The cats were all obtained from the same 
supplier and the surgical procedure began at the same time of day, about 
9:30 A. M. Each cat was anesthetized with a compound mixture of 
o<.-chloralose, 60mg/kg; pentobarbital sodium, 6mg/kg; and atropine 
sulfate, 1. 5mg/kg, administered intraperitoneally. The anesthetic mixture 
took about 20 - 30 minutes to produce surgical anesthesia wl1ich could last 
up to 24 hours; however, the cat was sacrificed by intravenous injection of 
air and heart puncture at the end of each experiment. 
Surgical Procedures 
The in vivo surgical procedure began with a tracheotomy to assist the 
cat in respiration and also to allow appropriate artificial respiration to be 
instituted after muscle relaxants were administered. One cannula was 
inserted into the internal carotid artery from which systemic blood 
pressure was monitored and a second cannula was inserted into the external 
jugular vein to allow systemic drug administration. 
The method used for the preparation of the anterior tibialis muscle 
was that of Brown (1938) as modified by Blaber (1960). The muscle was first 
exposed by cutting through the skin on the lateral side of the lower limb from 
" 
the ankle to just below the knee. The muscle could be completely exposed by 
cutting the transverse ligament. The origin of the muscle at its tendon was 
then freed by cutting it away with a piece of the bone attached. At this 
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time an opening was made into the popliteal space so that the sciatic nerve 
could be tied and severed and also a ligature be placed around the popliteal 
artery. This ligature would be used during close-arterial drug injection to 
insure that no dilution or washout of the drug has occurred. The peroneal 
nerve was isolated and freed for indirect stimulation. The entire hind 
limb was mounted using drills, one placed in the head of the femur and the 
other in the tibia and fibula. Having the lower limb fixed in position, the 
muscle was raised to expose the tibial artery lying between its belly and 
the bone. The distal end was ligated and separated from its accompanying 
sheath containing a vein and nerve. A fine polyethylene cannula was then 
inserted so that drug injections could be made in a retrograde fashion 
toward the heart, i.e. directly toward the muscle. A ligature around the 
tendon was now placed over a pulley system and attached to a Grass Force 
Displacement Transducer which was connected to a Dynograph. Proper 
muscle length and tension was determined by aligning the bone attached to 
the tendon with its original location in the piece of metatarsal. The muscle 
was thus situated so as to provide an isometric type of recording. 
In experiments involving measurement of blood flow, the flow was 
measured as the venous effluent from the tibialis muscle by cannulating 
the femoral vein; the method w~s modified from Bowman and Zaimis (1958). 
A fourth cannulation was required in those experiments in which a constant 
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infusion of muscle relaxant was required. In those instances a cannula 
was inserted into the contra-lateral femoral vein of the leg that was being 
used to record muscle contractions. A constant infusion was maintained 
using a Sigma pump. This entire surgical procedure requires about one 
and one-half to two hours so that the actual experiments began around noon. 
In experiments dealing with chronic denervation, the animals were 
anesthetized with pentobarbital sodium, 36mg/kg, I.P. While the animals 
were under anesthesia a small opening was made into the popliteal space 
so that a piece of the sciatic nerve, about 1 to 2cm long, could be removed. 
Terramycin topical powder (Pfizer) was then administered into the opening, 
the opening sutured, and more topical antibiotic applied. The animals were 
then cared for over a period of 14 - 17 days after which the usual surgical 
preparation was employed. 
In experiments dealing with acute denervation, the nerve was removed 
as above, but the actual experiment was carri.ed out forty-eight hours after 
the nerve section. At this time, the usual indirect stimulation of the 
preparation was attempted. In all cases, the preparation was able to be 
stimulated indirectly, but the degree of response va~ied. 
The in vitro surgical pro'cedure was much shorter than the in vivo 
procedure. Cats were anesthetized as before but neither a tracheotomy 
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~· nor any cannulations were required. The tenuissimus muscle is a deeper 
muscle of the hind limb than the tibialis. To isolate it, an incision was made 
beginning lateral to the knee and proceeding the entire length of the popliteal 
space. The lower portion of the muscle can be seen lying in the space, 
but the upper portion is hidden beneath the biceps femoris. The biceps 
can be severed using a cautery tip; caution is necessary nearing completion 
of this procedure so as not to damage the tenuissimus adhering to its 
fascia. The entire tenuissimus could be visualized and easily removed 
after clearing away some of its connective tissue. Care must be main-
tained so as not to damage its very small bifurcated nerve arising from 
the sciatic on which the muscle frequently appears to lie. After freeing 
the muscle from the biceps a suture was placed around each distal end 
of the muscle with a third suture tying off the nerve as close to the sciatic 
as possible. 
The entire nerve-muscle preparation was removed from the cat 
and maintained in an isolated tissue bath. Once in the bath and receiving 
proper nutrient solutions and gases the preparation was further cleaned 
under a dissecting microscope by using micro-surgical tools. This entire 
procedure, from opening of the leg to placing the muscle in the tissue bath 
took about fifteen minutes. ' 
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Recording and Stimulating Procedures 
All in vivo records were collected on an ink-writing Beckman Type-R 
Dynograph. Systemic blood pressure was monitored by means of a 
Statham pressure transducer. Muscle contractions were recorded employing 
a Grass Force Displacement Transducer. Blood flow was measured with 
a South Carolina Instruments Flow Meter. Intramuscular temperature was 
recorded via a 25G needle thermistor (Yellow Springs Instruments). The 
thermistor was carefully situated in the belly of the tibialis muscle to 
give accurate measurement with minimal muscle damage. 
In vitro records were collected as oscilloscope tracings after filming 
with a 35mm Lehigh ValleyOscilloscope Camera. Oscilloscope sweep speeds 
and camera film speeds were synchronized to obtain an accurate record of 
the particular experiment (Fig. 3). Final measurements of filmed data were 
made after enlargement with a Durst enlarger. 
In vivo preparations which required indirect stimulation were shocked 
by supramaximal, cathodic stimuli from various Grass stimulators 
available. Only denervated preparations required a stimulation duration of 
greater than 50 to 100 µsec. In acutely denervated preparations indirect 
stimulation was only employed; a tenfold greater than normal voltage was 
' 
required in all of these preparations. In chronically denervated preparations 
only direct stimulation was applied which was passed over the muscle be-
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CA-5 
Figure 3. Diagram of the apparatus employed during 
in vitro studies. CROs are oscilloscopes for view-
ing and filming; CA-5 is a signal calibration device; 
S-8 is a two independent output stimulator; 25x is a 
binocular dissecting microscope; the bath temperature 
is maintained at 37~c. 
'C 
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tween two platinum wires, one inserted in the belly of the muscle and the 
other wound up around the tendon. Compared to indirect, direct stimulation 
required a longer duration, about 0. 5msec and a greater voltage, 90 to 
100 volts. By direct observation the denervated muscle was decreased in 
size and did not have the usual pink appearance of the normal muscle. The 
preparation was tested as to its denervation by trying to stimulate the 
nerve and record a muscle contraction. In all of the cases this did not occur. 
The main nerve to the isolated tenuissimus muscle was stimulatec 
via two bipolar platinum electrodes housed in a chamber adjacent to the 
main tissue bath. The tissue bath (nerve and muscle chambers) was made 
of plexiglass material. 
The dimensions of the actual muscle chamber were 70mm x lOmm 
with a maintained fluid level of 4mm, producing a solution volume calculated 
3 3 
to be 2800mm or. 2. Bern . The bath was an overflow type, i.e. a dam 
was situated opposite the inflow and near the outflow maintaining the constant 
fluid level. The inflow to the bath was via an 18G needle attached to an I. D. 
0. 045': polyethylene tubing. This tubing coursed through a lOOml heated 
condensing column which was fed by a nutrient Ringer solution maintained 
65 cm above the muscle bath in 500ml leveling bulbs. A constant temper-
ature of 37°C + O. l°C was maintt:tined across the area in which the nerve and 
muscle was situated by preheating the perfusion solution using a constant 
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temperature Haake pump. The flow was adjusted between the leveling bulbs 
and condensing column by means of a screw clamp and maintained at an 
average rate of 500ml/hr. This rate of necessity varied, but was always 
adjusted to maintain this average flow rate. 
The floor of the muscle chamber had balsa wood at its edges to which 
the uncut muscle was pinned over a plexiglass center for transillumination 
of the muscle from below and viewing of the endplate area from above. In 
the case of cut fiber preparations the muscle was pinned on each side of the 
central plexiglass base. After cutting the portions of muscle lying on the 
outer edges of these pins a section of tissue remained which was 9mm long 
{the length of the plexiglass}; if cut properly, it did not contract upon 
indirect evoked stimulation. Whenever a muscle fiber continued to twitch 
following stimulation a fine scalpel was used to crush or cut the muscle 
closer to any visible nerve terminals; care was exercised so as not to 
damage any of the fine nerve endings. 
Intracellular recording was accomplished with glass capillary tubing 
pulled to a fine tip using a Kopf Fast Co. vertical micropipette puller. 
The electrodes were filled under vacuum with ethyl alcohol which was 
displaced first by distilled wate'r and finally by 3M KCl. The resistance of 
each electrode was tested prior to an experiment and the electrode 
• 
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considered satisfactory if its resistance was greatei: than 4 megohms. 
Resistances of up to 30 megohms could be employed if they did not produce 
excessive signal noise. A fine Ag-AgCl coated silver wire was placed 
within the electrodes and connected to a d. c. amplifier. A Bio electric 
Instrument NF-1, d. c. amplifier was employed and potentials were further 
amplified and viewed through a Tektronix 502-A dual beam ~scilloscope. 
A calibration signal was also amplified by inserting a Bioelectric Calibrator 
CA-5 into the circuit (Fig. 3). Potentials were recorded with respect to 
another Ag-AgCl coated silver ground wire immersed in the bathing solution. 
In experiments utilizing two intracellular electrodes, one for 
recording and the second to pass current, a modification of the previously 
described apparatus was employed. In addition to the recording apparatus 
and circuit as seen on the right of Fig. 3, a second electrode, stimulator 
and recording system was added as seen on the lower left of Fig. 3. This 
second electrode, made as before, was used to pass current through the 
cell in which it and the recording electrode was impaled. The current 
was amplified by means of a Nihon Hi-Input Impedance d. c. amplifier, 
Model-M2-3A and displayed on the lower beam of a Tektronix 502 
oscilloscope. The upper beam of the oscilloscope displayed the electrotonic 
" potential induced by this current electrode, via the recording electrode. 
The circuit used for this procedure was a modification of that employed by 
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Fatt and Katz (1951). In place of their 0. 5 µF capacitor a 500 M resistor 
was used so as to produce a more rectangular currect. pulse. Current 
pulses had a duration of 600 to 800 msec in the midst of which an evoked 
epp could be imposed. With this recording technique one .could obtain the 
extrapolated equilibrium potential and input resistance of a particular cell. 
Grounded aluminum foil was positioned between the two electrodes to 
minimize interference signals. 
After the surgery was completed and recording and stimulating 
apparatus attached to the in vivo preparation supramaximal cathodic stimuli 
of 0. 1/ sec frequency were began. A 15 to ·30 minute interval was allowed 
to lapse before any drugs were administered. This interval was established 
so that the preparation could equilibrate at the constant intramuscular 
temperature of 37°C which was maintained by various heat lamps. 
Drugs were injected either close-arterially or intravenously. The 
volume of close-arterial injections was 0. 2ml. Intravenous injections were 
carried out in larger volumes, the largest being 5 ml. No strict time 
regimen was maintained although a minimal interva~ was allotted for the 
drug to be washed through the system and the preparation return to control. 
' In experiments during which responses to close-arterial injections 
of ACh were recorded the stimulator was turned off prior to, during and 
after the injection, altogether for a period of about 40 sec (Fig. 9). 
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After mounting the tenuissimus muscle in the isolated tissue bath and 
cleaning away the remaining connective tissue adhering to the preparation, 
superficial nerves could be visualized with the aid of a Zeiss binocular 
dissecting scope (15-·lOOx). Microelectrodes were mounted to a Narishige 
mic:ro-manipulator and the endplate region was located by varying the 
position of the microelectrode until the site was found where mepps and epps 
had the shortest rise-time and the greatest amplitude. 
· l\iliniature endpla.te potentials (mepps) were recorded after a control 
period of fifteen minutes. This period of time was maintained to allow the 
cell, once it had been impaled with an electrode, to equilibrate at resting 
potentials of -70mV or greater. Only cells 'vhich displayed mepps with a 
rise-time of less than lmsec were satisfactory. In the study of frequency 
and amplitude distribution thirty oscilloscope sweeps, each of 1 sec duration 
were col1ected. The oscilloscope was set at a horizontal time base of 
0. lsec I cm, the vertical time base was set as a spot, and suitable camera 
speed er.cl.ployed to produce on the film at least thirty, one second sweeps of 
data with a convenient interval. The resultant recording allowed frequency to 
be determined either as an event per second or else· a total number of 
events per fixed period of time. cg. 30sec. The recording could also be 
' 
used to measure the amplitudes of the mepps since a calibration pulse 
was distributed intermittently amongst the latter. Thus, from these sweeps 
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a disti rbution histogram of control and treated prep~rations was constructed. 
Paired statistics were determined from a series of experiments in which a 
Latin Square design was invoked to determine the optimal concentration of 
the drug. The design was such that four log differential doses of catechol 
were compared each in the same animal as well as in other animals. A 
control record was taken after fifteen minutes, the drug administered and 
records taken for fifteen minutes; this was then followed by thirty minutes 
of recording following the washout of the drug. This cycle was repeated for 
subsequent drug administration. In early experilnents recordings were 
taken after five minutes of the drug action at minute intervals with a 
plateau of effect seen between five and ten minutes. For this reason, a 
fifteen minute cycle was strictly maintained in all subsequent in vitro 
experiments. After determining the optimal dose from these results on 
mepp frequency, this dose was used throughout the research problem. 
Effects of catechol upon rise-time, half-fall, amplitude, and resting 
potential of mepps were determined in another series of experiments in which 
essentially the same experimental design was used as that described; 
however, the oscilloscope horizontal time base was .altered to O. 2msec/ cm 
and the vertical sweep was adjusted as needed. A calibration pulse of lmsec 
duration and O. 5mV in amplitud'e was inserted to quantify the individual 
potentials. Single frame pictures were taken after fifteen minutes of at 
least fifteen control sweeps, the drug administered for fifteen minutes 
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and single frame pictures taken of at least fifteen treated sweeps. These 
were pooled and a paired statistic was calculated from the data obtained 
with seven different animals. 
A drug effect upon endplate potentials (epps) was studied by blocking 
the muscle in two ways. Since the in vivo studies showed that catechol and 
phenol antagonized the d-tubocurarine block, initial studies of epps were 
instituted in the d-Tc blocked muscle. Epps evoked at a rate of 0. 1 or 0. 5/ 
sec were collected under both control and experimental conditions, i.e. 
following d-tubocurarine, 2. 9-5. 7xl0- 6M, or d-tubocurarine, 2. 9-5. 7xl0- 6M 
+ catechol lxl0- 5M. These epps were measured as to amplitude, rise-time, 
half-fall and resting potential. The protocol followed a similar sequence to 
that employed in the mepp studies. A control record was taken after 
fifteen minutes, the drug administered and records taken after fifteen min-
utes. A calibration signal was inserted before each evoked signal to 
quantify accurately the results. 
The second method utilized to block the muscle was that of the cut 
fiber technique of Barstad and Lilleheil (1968). This method has been 
adapted for use in the tenuissimus muscle by Blaber (1970). Cut fiber epps 
were collected as described for 11 curarized" epps and the same parameters 
' 
measured. In analyzing a drug effect upon epp amplitude, rise-time, half-
fall and resting potential a paired single-tailed Student's "t" test was 
used on the pooled data. 
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Trains of epps were recorded to analyze the drug effects in both the 
! i, curarized muscle and the cut fiber preparation (Elmqvist and Quastel, 1965). 
In the case of the curarized muscle, a tetanus of 50/sec, once every 
minute, for one second was induced. The resultant train of epps was 
divided into two main sections. The first fifteen epps were classified as 
the 'head' of the train; they depict an initial depletion of transmitter. The 
remaining epps of the train, the 'tail', constitute an equilibrium state of 
transmitter release due to a mobilization from a pool wherein the 
transmitter is stored. Each epp was measured to the nearest mm after 
2-3x enlargement using a Durst enlarger. 
This same technique was used in the case of cut fiber preparations 
with the following modifications. Instead of a tetanus frequency of 
50/sec a frequency of 200/sec was required to establish a run-off suitable 
for the plot of a regression line (Blaber, 1970). Using a train duration of 
0. 5sec, 100 epps could be recorded. The program was instructed in this 
instance to use as before the first 15 epps as the 'head' but now divided 
the remaining eighty-five potentials into eight groups of ten-omitting the 
last five of the 'tail' - for computing the variance. 
These data along with the resting potential and assumed equilibrium 
' potential of -15mV were key punched into a program written for CDC 6400 
computer. 
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Calculations 
The computer program employed Martin's (1955) correction for each 
endplate potential: EPP 
(RP-15) - EPP x (RP-15). 
The program then divided the 'tail' portion of the train into approrpiate group 
of five or ten epps, computed the variance of each group, and estimated the 
quantum size from the variance. These determinations are derived from the 
nature of the quantal release which follows the Poisson Distribution. If the 
quantal contents of individual synaptic potentials in a series are distributed 
according to the Poisson equation, then the coefficient of variation (C. V.) of 
the quantal content distribution should be equal to 1/ M (Edwards and Ikeda, 
1962). Using this property the following relationship may be derived after 
Edwards and Ikeda (1962): 
Eq. 1. 
1 
c. v. = Quantal Content 
OR 
Quantal Content = 1 
-""--
c. v. 2 
Moreover, the following relationship may be derived after 
del Castillo and Katz (1954): 
Eq. 2. " 
Quantal Content = epp OR mepp = epp 
mepp Quantal Content 
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Combining Eq. 1. and Eq. 2. one may obtain: 
Eq .. 3. 
- epp 
mepp - l/C~.'=v-.29-
Following Goldstein (1969) Eq. 4. may be derived: 
S. D. 
c. v. = 
mean 
Eq. 4. 
2 c. v. = 
AND 
Variance 
mean2 
Variance 
\ 
= S. D. 2 
Combining Eq. 3. and Eq. 4. for a series of epps one obtains the following 
set of equations (Eq. 5. and Eq. 6. ): 
Eq. 5. 
mepp = (epp) 
.Variance 
2 (epp) 
Eq. 6 . 
mepp = 
(q) 
Variance 
epp 
The mean estimate of the quantum size (q) was used to calculate the 
quanta! content of each epp and the mean quanta! content of the epps 
comprising the 'tail'. Mobilization rate ( dm) was estimated as the mean 
quanta! content of the 'tail divided by its stimulus interval. The stimulus 
interval is the "dme in msec between pulses in a tetci.nus. This interval 
varied depending on the preparation. The stimulus interval in d-tubocurarine 
blocked preparations was 20 m"sec since the frequency of the tetanus was 
50 I sec. The stimulus interval in cut fiber preparations was 5 msec 
since these preparations were tetanized at 200 I sec. From the quanta! conten 
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of each of the first 15 epps and the cumulative quanta! release, the program 
calculated a series of correlation coefficients which described the linearity 
of a regression line resulting from the early decline of quanta! content. 
Arbitrarily, the fifth point was chosen as the point which began to deviate 
from a linear relationship. Blaber (1970) had in fact determined that the 
sixth epp of each train stimulated at 200/sec was the last point to remain on 
this regression line. 
The program calculated the extrapolated point on the 'y' axis which 
was equivalent to the quanta! content of the first endplate potential (M0); 
the program calculated also the extrapolated intercept on the 'x' axis which 
constituted the size of the available store of quanta (n). The fraction of the 
store released by the first impulse probability of release (p) was 
calculated by dividing the quanta! content of the first endplate potential by the 
readily releaseable -store (M0 /n). Elmqvist and Quastel (1965) have pointed 
out that when this method is applied in a situation where the probability of 
release is variable, the estimate of 'q' derived from its variance will be 
smaller, but not necessarily less than the actual value for quantum size. 
In the determination of Mo, n, p, q, and dm a paired statistical 
' 
analysis was performed. The control for each animal was taken at a time 
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fifteen minutes after impalement of the cell. The drug was then perfused 
and a record was taken fifteen minutes later. In most experiments more 
than one set of controls and experimental results were recorded in order to 
insure filming the data. In instances when more than one record was 
available control and experimental data were averaged. 
Calculations involving the determination of equilibrium potential and 
membrane resistance were as follows. Plots of applied current vs. 
membrane potential change were drawn by fitting the best line through the 
experimental results and the x-y intercept. Input resistance was calculated 
by dividing the value of the curre~t applied to the preparation into the 
resultant amplitude of the electrotonic potential. Both the current and 
electrotonic potential could be measured directly from the oscilloscope 
recordings. Using the method of least squares a line was plotted through 
the experimental points obtained from the change in membrane potential 
vs. the change in epp a.mplitude. This line extrapolated to the x-intercept 
was the equilibrium potential for the given cell. This protocol was employed 
in cut fiber prepa:r;-ations before and after the additiOn of catechol. 
Solutio11s and Drugs 
All the drugs used in the study were dissolved in normal saline solution 
and diluted as required. There are two exceptions to this statement: 1) 
r 
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A cetylcholine HCl manufactured by City Chemical Corporation was 
dissolved in distilled water and maintained at a pH of less than 4. 0 by the 
addition of HCl. The resultant solution was stable if kept under refrigeration. 
2) Phenoxybenzamine HCl, supplied by Smith, Kline and French Labora-
tories, had to be solubilized for intravenous injection by the method 
described in Martindale's Pharmacopia, pp. 1441-2. The remaining drugs 
and their suppliers were: d-Tubocurarine, Abbott Laboratories; d, 1-Pro-
pranalol, Imperial Drug Co., Ltd.; Neostigmine Dr. City Chemical 
Corporation; 1-Epinephrine HCl, Winthrop Laboratories; Dopamine HCl, 
Sigma Chemical Corporation; Phenol-crystals, J. T. Baker Chemical Co.; 
Aminophylline, G.D. Sea:de and Co.; Benzoquinonium HCl, Sterling-
Winthrop Labs. and Catechol, Eastman Organic Chemicals. 
The irrigating solution for the in vitro preparation was described by 
Krebs and Henseleit (1932) and consisted of the following components; 
NaCl 
KCl 
KH 2P04 
NaHC0 3 
CaC~2 
MgSU4 
d-Glucose 
115mM 
4. 60mM 
l.15mM 
24. lmM 
2. 46mM 
1.15mM 
8. 85mM 
This solution was bubbled with 95% oxygen and 5% carbon dioxide. In 
preparations that required the ~ddition of d-tubocurarine to permit recording 
of epps or their trains the drug was added in a dose of 2. 9-5. 7x10- 6M. 
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PHENOL 
CATECHOL 
QH 
HQH 
Figure 4. Chemical structures of some of the compounds 
investigated in this dissertation. 
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RESULTS 
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Antagonism of d-tubocurarine blockade: 
In twenty-two experiments, d-tubocurarine (d-Tc) was given 
intravenously either in single injection ( 500µg) or in slow perfusion (1. 2-
1. 8mg/hr) to produce in all cases approximately 80% blockade of the 
muscle. Various doses of catechol or phenol were effective in antagonizing 
d-Tc, the optimal dose being 50µg and 250µg respectively (Fig. 5 and 6). 
The effects of catechol and phenol were then compared to epinephrine ( 5.ug) 
or dopamine (lmg) in ten other experiments. Epinephrine produced a 
depression after an initial antagonism. This secondary depression by 
epinephrine had been first reported by Naess and Sirnes (1953). Dopamine, 
on the other hand, only produced a depression (Fig. 7) after d-Tc. 
In twelve cats, catechol and phenol were administered in the presence 
of the alpha-adrenoreceptor blocking drug, phenoxybenzamine (5mg/kg, i. v. ); 
in ten cats the beta-adrenoreceptor blocking drug, propranalol 
(2mg/kg, i. v.) was given prior to catechol or to phenol. The antagonism by 
catechol or phenol was unchanged in the presence of either of the adreno-
receptor blocking drugs (Fig. 5 and 6). The initial antagonism produced 
by epinephrine was abolished after the alpha-blocker (Maddock, Rankin, 
and Youmans, 1948), but was still prominent after the beta-blocker 
If 
(Bowman and Raper, 1966). The depression or "curaremimetic" action of 
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c c c 
Tc C Bz c. 
Ph Tc C Pr Tc 
Figure S. The effects of catechol in innervated cat 
anterior tibialis muscle. At C, catechol was injected 
close-arterially in the dose of SOpg,_except in the 
upper rirht hand panel where the dose was 20mg. At Tc, 
d-tubocurarine (O.SmR, i.v.), at Bz, benzoquinonium 
(0.2Smg, i.v.), at Ph, phenoxybenzamine (Smg/kg, i.v.), 
and at Pr, propranaiol (2mg/kg, i.v.) were injected. 
Calibration = Smin x O.Skg 
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p p 
Tc p 
Figure 6. The effects of phenol in innervated cat 
anterior tibialis muscle. At P, phenol in the dose 
of 2SOµg was injected close-arterially, except in the 
case of the upper right hand panel where the dose was 
lOmg. At Tc, d-tuhocurarine (O.Smg, i.v.), at Bz, 
benzoquinonium (0.25mg, i.v.), at Ph, phenoxybenzamine 
(Smg/kg, i.v.), and at Pr, propranalol (2mg/kg, i.v.) 
were injected. Calfbration = Srnin x O.Skg 
r 
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D 
I ( 
T D 
Figure 7. Effects of dopamine in innervated cat 
anterior tibialis muscle. At D, dopamine was in-
jected close-arterially in the dose of lmg. At T, 
d-tubocurarine (O.Smg, i.v.) was injected. 
Calibration = Smin x O.Skg 
' 
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dopamine could not be affected by either type of blocking agent (Ferko 
and Calesnick, 1971). 
Antagonism of benzoquinonium blockade: 
In six experiments, benzoquinonium was administered as a single 
injection (250µg), and catechol (50µg) or phenol (250µg) was given close-
arterially at the peak of the block (Fig. 5 and 6). Both compounds antago-
nized the paralysis. Both compounds also appeared to antagonize the 
benzoquinonium block faster than the d-Tc block. A quicker complete 
antagonism, may be attributed to the presynaptic facilitatory effect of low 
doses of benzoquinonium (Christ and Blaber, 1968), which adds to a possible 
presynaptic facilitatory action of catechol. Epinephrine was also shown to 
antagonize benzoquinonium (Bowman, 1958). 
Effect on maximal contraction: 
In eight experiments, doses of catechol or phenol previously shown 
to antagonize d-Tc only slightly augmented the indirectly excited 
contraction. The average facilitation observed with catechol (50µg, c. a.) 
and phenol (250µg, c. a.) was 2. 5% and 9%, respectively (Fig. 5 and 6). 
However, in higher doses, catechol (20mg) and phenol (lOmg) either had a 
" biphasic action, consisting of partial block and facilitation, or produced 
complete block (Fig. 5 and 6). In five experiments, the "curaremimetic" 
• 
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dose of dopamine (lmg) always caused about 10% augmentation of the 
contraction (Fig. 7). 
In five experiments, catechol (50pg to lOmg) or phenol (lOOµg to lOmg) 
had no effect on chronically denervated, directly stimulated preparations 
(Fig. 3). Catechol or phenol did not produce contraction when injected 
close-arterially in the case of either the innervated or denervated muscle. 
No fibrillations were recorded after their injection into denervated 
muscles. 
Using the method of Okamoto and Riker {1969) six experiments were 
performed on subacutely denervated ( 48 hours prior to the experiment) 
preparations. The muscle was stimulated· indirectly, and single doses of 
d-Tc were administered to produce an 80% block. At this level of block, 
either catechol {50pg) or phenol {250µg) was injected close-arterially. The 
d-Tc-catechol and d-Tc-phenol antagonism were either abolished or 
markedly reduced by the subacute denervation (.Fig. 8). This procedure 
also appeared to reduce or eliminate the slight facilitation produced by 
either compound in normal preparations. 
Effect on responses to close-arterially injected acetylcholine: 
Figure 9 shows the effects of catechol on the response to close-
' 
arterially injected ACh during an infusion of d-Tc. In all five experiments, 
there was no increase in the ACh-induced contraction in the presence of 
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_J 
Figure 8. Effects of catechol and phenol on chronically 
denervated (upper panels) and subacutely denervated 
(lower panels) muscles. At C, catechol (SOpg, c.a.), at 
P, phenol (250pg, c.a.), and at Tc, d-tubocurarine (O.Smg, 
i.v.) were injected. Calibration = Smin x 0.25kg. 
' 
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catechol, but, rather, an initial depression at the peak of the d-Tc-catechol 
antagonism. A Ch contractions returned to the control height shortly 
thereafter. 
Effect of blood flow upon drug action: 
No particular vascular effect seemed to be related to the drug 
responses. In five animals, catechol ( 50µg, c. a.) and phenol (250µg, c. a.) 
consistently produced a vasoconstriction; an average 25 and 44% decrease of 
flow was induced by catechol and by phenol, respectively. These effects 
were compared to those of 5µg and 25µg doses of epinephrine given c. a. and 
i. v. respectively. Either route of administration caused an average decreas 
in flow of 7 5%. On the other hand isoproterenol, at 50µg, i. v. , enhanced 
the flow rate by 40%. Bowman and Raper (1966) comparing the three 
catecholamines, epinephrine, norepinephrine, and isoproterenol, concluded 
that the observed contractile muscle responses were independent of the 
accompanied vascular effects which may have been due to the administration 
of the drugs. An earlier report by Bowman and Zaimis (19 58) demonst;rated 
that when epinephrine and norepinephrine are administered in very high 
doses which caused a marked vasoconstriction, this vasoconstriction could 
produce a depression of both submaximal and maximal tetanic tensions. 
' This depression could be prevented by the prior administration of adrenergic 
receptor blocking substances. No reports have described in full the effects 
of drugs upon blood flow during a d-Tc paralysis. 
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Figure 9. The effect of catechol on the response to 
close-arterially injected acetylcholine. At Tc, a 
constant infusion of d-tubocurarine (l.Zmg/hr, i.v.) 
was started. At A, acetylcholine (80µg, c.a.) and at 
C, catechol (SOµg, c.a.) were injected. 
Calibration = Smin x O.Skg 
' 
89 
' Effect of combinations of catechol and phenol with neostigmine and 
aminophy lline: 
Breckenridge et al. (1967) concluded that a combination of epine"".' 
phrine and neostigmine produces a beta-adrenergic effect on the nerve 
terminal, which could be augmented by the concomitant administration of 
\ 
aminophylline. In a series of experiments, the same procedure as that of 
Breckenridge et al. (1967) was employed to examine this question and the 
results are shown in Tables 1. and 2. Table 1. presents the average 
measurements of the facilitation produced by the individual drugs, catechol, 
phenol, neostigmine and aminophylline; Table 2. shows the average 
facilitation produced by the various drug combinations. Figure 10 
illustrates a typical experiment. The effects of catechol, phenol, or 
epinephrine were augmented by neostigmine and further increased, quite 
markedly, by aminophylline. Neither propranalol nor phenoxybenzamine 
abolished the effects of the aminophylline when combined with phenol or 
catechol, although both produced some degree of inhibition. A mixture of 
epinephrine (0. 2µg close-arterially) and neostigmine (20µg, i. v.) produced 
a 22% increase in contraction height; when aminophJ:lline (25mg/kg, i. v.) 
was added to the combination, a 64% increase in contraction height was 
produced. In four instances, pretreatment with propranalol (2mg/kg, i. v.) 
reduced the augmentation of the epinephrine-neostigmine-aminophylline 
combination to 27%, thus confirming the results of Breckenridge et al. (1967). 
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Figure 10. The effect of combinations of neostigmine 
and aminophylline with catechol or phenol on muscle 
contractions. At N, neostigmine (20µg, i.v.), at C, 
catechol (SOµg, c.a.), at P, phenol (ZSOµg, c.a.) and 
at A, aminophylline (25mg/kg, i.v.) were injected. 
Calibration = Smin x O.Skg. 
' 
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TABLE 1. Percentage Facilitation of Muscle Contraction 
Catechol Phenol Neostigrnine Aminophylline 
.. 
(SOµg,c.a.) ( 2 S Opg , c . a • ) (20pg,c.a.) (2Srng/kg, i. v.) 
. MEAN 2.S 9.0 29.3 30.0 co 
+S.D. +0.3 +1. 7 +6.2 +11.2 ...... 
N 4 4 20 3 
Control - Treated Contraction 
% Facilitation = x 100 
Control Contraction 
TABLE 2. Percentage Facilitation by Drug Combination 
Catechol (SOµg,c.a.) Phenol (ZSOµg,c.a.) 
+ + 
Neostigmine (20µg,c.a.) Neostigmine (20pg,c.a.) 
.. 
MEAN + S.D. N MEAN + S.D. N 
co 
CONTROL 49.3 + 12.5 11 47.3 + 24.0 6 ~ 
+Aminophylline 94.3 + 16.3 12 88.1 + 16.9 10 
(25mg/kg,i.v.) 
+Aminophylline 88.0 + 19.1 3 82.5 + 6.3 4 
(Pretreated with 
phenoxybenzamine 
Smg/kg,i.v. 
+Aminophylline 85.6 + 26.4 6 76.S + 25.9 6 
(Pretreated with 
propranalol 
Zmg/kg, i. v.) 
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Effect of catechol upon miniature endplate potentials (mepps): 
Mepps were obtained as described in the METHODS section. Initial 
experiments were undertaken to determine a dose-response relationship 
for catechol on the isolated nerve-tenuissimus preparation. In vivo, catechol 
was unable to stimulate directly the postsynaptic membrane in either inner-
vated or denervated muscle. Furthermore catechol was unable to induce 
sensitization or demonstrate anti-ChE activity as evidenced by the fact that 
it did not affect the response to c. a. injections of ACh. Thus, a possible 
presynaptic mechanism of action could be expected, and it was first 
attempted to elucidate this possibility by an examination of mepp frequency. 
The effects of three concentrations of catechol (l0- 7M, 10-6M and 10-5M) 
were analyzed (Table 3). An increase in frequency was observed with both 
the 10-6M and 10- 5M doses; while frequently it was impossible to maintain 
the electrode within the cell in the case of a 10- 4M concentration, a decrease 
in frequency was noted in the successful experiments. 
The results obtained in nine different cats were analyzed in terms of 
mepps observed over a thirty second period (cf. Methods). From these 
same experiments a distribution of mepp amplitudes was also obtained; 
no apparent change was observed at any of the concentrations studied. 
Histograms of the frequency dititribution (N=999) and of the amplitude 
distribution (N=l217) were constructed from mepps observed in control and in 
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TABLE 3. 
EFFECTS OF CATECHOL ON MEPP FREQUENCY 
FREQUENCY OBSERVATIONS OVER THIRTY SECOND PERIOD 
CONTROL-l0-7M-CONTROL-l0-6M-CONTROL-10-SM-CONTROL 
CAT 
CAT 
CAT 
CAT 
CAT 
CAT 
CAT 
MEAN 
+S.E. 
I 
II 
III 
IV 
v 
VI 
VII 
52 
68 
44 
37 
60 
39 
50.0 
+5.0 
56 
85 
36 
58 
56 
62 
58.8 
+6.4 
52 
40 
44 
62 
59 
53 
65 
53.6 
+3.5 
61 
87 
SS 
87 
61 
69 
10.0* 
+S.7 
61 
58 
44 
65 
50 
60 
56.3 
+3.2 
74 
98 
68 
89 
66 
71 
77.7* 
+5.3 
**The difference is statistically significant at p < .0025 
* The difference is statistically significant at p <.OS. 
If 
57 
83 
52 
83 
67 
57 
66.5 
+5.6 
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Figure 11. The frequency distribution of control mepps 
(solid line) and rnepps in nine preparations treated with 
lxlo-SM catechol for fifteen minutes (dashed line). The 
mean values obtained for control and treated prepara-
tions were 2.2 and 3.2 mepps/sec, respectively. 
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Figure 12. The amplitude distribution of mepps obtained 
in control (solid line) and thirteen treated prepara-
tions (dashed line). Catechol, lxlO-SN was added to the 
control and results collected after fifteen minutes. 
The mean amplitude of both control and treated prepara-
tions was equal (O.SOmV). 
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TABLE 4. 
EFFECTS OF CATECHOL, lx10-5M, ON MINIATURE E.P.P.s 
CONTROL 
(N=7) 
TREATED 
(N=7) 
Amplitude 
(mV) 
0.58 
+.03 
0.60 
+.03 
Rise-time 
{msec) 
0.45 
+.02 
0.48 
+.01 
Half-fall 
(msec) 
0.95 
+.03 
1.01 
+.02 
The differences are not statistically significant. 
R.P. 
(mV) 
74.0 
+2.3 
74.4 
+2.4 
Data pooled from seven cats and expressed as mean + standard 
error. 
" 
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A 
\\ 
c 
• 
B 
Figure 13. Epp before (panel A) and after (Panel B) 
lxlo-SM catechol. In both cases d-tubocurarine 
(4.3xlo-6M) was employed. The square-calibration 
signal is 2mV x lrnsec. 
" 
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TABLE S. 
EFFECTS OF CATECHOL, lxlo-SM, ON E.P.P.s IN d-Tc 
CONTROL (N=4) 
TREATED 
(N=4) 
Amplitude 
(mV) 
3.35 
+.4S 
4.12* 
+.SS 
Rise-time 
(msec) 
0.53 
+.10 
O.S2 
+.07 
Half-fall 
(msec) 
1.43 
+.27 
1.34 
+.4S 
R.P. 
(mV) 
76.S 
+3.8 
76.0 
+4.2 
*The difference is statistically significant at p< .01. 
Data pooled from four cats and expressed as mean + standard 
error. 
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Figure 14. Epp before (Panel A) and after (Panel B) 
lx10-SM dopamine. In both cases d-tubocurarine 
(4.3xlo-6M) was ~mployed. The square.wave calibra-
tion signal is 2mV x lrnsec. 
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TABLE 6. 
EFFECTS OF DOPAMINE, lxlo- 5M, ON E.P.P.s IN d-Tc 
CONTROL 
(N=3) 
TREATED 
(N=3) 
Amplitude 
(mV) 
5.19 
+.73 
4.48 
+1.31 
Rise-time 
(msec) 
0.47 
+.04 
0.42 
+.07 
Half-fall 
(msec) 
1.03 
+.37 
1.11 
+.46 
The differences are not statistically significant. 
R.P. 
(mV) 
74.7 
+11.8 
74.7 
+11.8 
Data pooled from three cats and expressed as mean ~ standard 
error. 
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preparations treated with lxl0- 5M catechol (Fig. ll and 12). The frequency, 
but not the amplitude distribution was significantly affected by this 
concentration of catechol, confirming the data shown in Table 3. Finally, 
individual mepps were analyzed in regard to a possible effect of catechol on 
rise-time, half-fall, amplitude, or resting membrane potential. These 
results are depicted in Table 4. As can be seen, there was no significant 
change in any of the parameters measured. 
Effect of catechol and dopamine upon endplate potentials in d-Tc blocked 
muscles: 
Figure ·13 shows a typical epp in d-Tc on the left (A) and the effect 
-5 
of lxlO M catechol added to d-Tc on the right (B). In two of four instances 
it could be seen microscopically that some muscle fibers of the preparation 
began to twitch after perfusion with catechol. Table 5 summarizes this 
effect of catechol upon epp amplitude, rise-time, half-fall and membrane 
potential. A statistically significant increase in the amplitude was observed 
in four different animals; the other parameters were not significantly 
affected. 
_5 . 
The effects of dopamine (lxlO M) on a representative epp in the 
presence of d-Tc are demonstrated in Fig. 14. Table 6 shows that there is 
' 
no statistical difference in any of the parameters measured; namely, ampli-
tude, rise-time, half-fall or resting potential. However, following the 
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treatment there was a small decrease in the amplitude of the epp as well as 
a slight prolongation of the half-fall. This decrease in amplitude recorded 
in d-Tc-treated preparations parallels the "curaremimetic" action of 
dopamine as seen in the in vivo preparation. 
Effect of catechol and dopamine upon storage and release of transmitter in 
d-Tc blocked muscles: 
The action of a drug can be pre- or post-synaptic or both. In order 
to separate such actions of a drug with regard to these sites the method of 
Elmqvist and Quastel (1965) was employed. A train of epps in d-Tc was 
compared to a train of epps in the same preparation treated with catechol 
-5 (lxlO M). Each train consisted of a tetanic stimulus at 50 I sec. A portion 
of a pair of these trains of epps can be seen in Fig. 15. Not much visible 
change can be observed in this typical experiment. Computer analysis 
shows however that an effect was obtained (Table 7). This analysis 
demonstrates a highly significant increase in the quantal content of the 
first epp (M0), as well as a highly significant decrease in quantum siz~ (q). 
The large increase in M0 can be explained by the concomitant significant 
increase in the probability of release (p) and mobilization (dm). The large 
decrease in q might be explained by the insufficient increase in the readily 
'f 
available stores (n); the turnover of transmitter that is demanded by the 
increase in q may be exhausting the available "mature" quanta and forcing 
"younger" quanta to be mobilized. 
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Figure 15. The first six and the last five epps of a 
tetanus before (Panel A, top and bottom, respectively) 
and after (Panel B, top and bottom, respectively) 
lxlo-SM catechol. Each tetanus was r~corde<l in the 
presence of d-tubocurarine (4.3x10-SM). Stimulus 
frequency = SO/sec. Calibration signal = SmV. 
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TABLE 7. 
EFFECTS OF CATECHOL, lxlo- 5M, ON STORAGE AND RELEASE 
OF TRANSMITTER IN d-Tc 
CONTROL 
(N=6) 
TREATED 
(N=6) 
Mo (quanta) 
230.6 
+41. 5 
526.9** 
+122.0 
n 
(quanta) 
1330 
+187 
2067 
+563 
p 
(M0 /n) 
0.186 
+.028 
0.276* 
+.048 
q 
(mV) 
0.015 
+.004 
0.010** 
+.003 
dm 
(quanta/msec) 
6.3 
+1.7 
lo.o* 
+2.9 
**The differences are statistically significant at p .01 
*The difference is statistically significant at p .OS 
Data pooled from six cats and expressed as mean ! standard 
error. 
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A B 
Figure 16. The first and last seven epps of a tetanus 
before (Panel A, top and bottom, respectively) and 
after (Panel B, top and bottom, respectively) lx10-SM 
dopamine. Fach tetanus was recorded in the presence 
of d-tubocurarine (4.3xl0-6M). Stimulus frequency= 
SO/sec. Calibration signal = SrnV. 
" 
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TABLE 8. 
\ 
EFFECTS OF DOPAMINE, lxlo- 5M, ON STORAGE AND RELEASE 
OF TRANSMITTER IN d-Tc 
CONTROL 
(N=3) 
TREAT 
· (N=3) 
Mo (quanta) 
264.0 
+69.7 
364.1 
+.115. 0 
n 
(quanta) 
1399 
+230 
2015 
+47,0 
p 
(M0/n) 
0.187 
+.042 
0.184 
+.044 
9 (mV) 
0.014 
+.007 
0.011 
+.001 
drn 
(quanta/msec) 
4.75 
+1.07 
6.80 
+2.00 
The differences are not statistically significant. 
Data pooled from three cats and expressed as mean ~ standard 
error. 
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Figure 16 represents a similar set of epps recprded in a d-Tc-treated 
preparation. In these experiments dopamine was added to examine its 
effects upon the storage and release of transmitter. Dopamine, unlike 
catechol caused a slight decrease in the amplitude of the first epp as well as 
a slight decrease in the amplitudes of 'tail' potentials. A further 
dissimilarity from catechol' s action was evidenced in Table 8, which shows 
that dopamine did not cause a statistically significant change in any of the 
parameters although small changes can be seen with regard to M0, n, q 
and dm. The greatest dissimilarity lies in the fact that dopamine in d-Tc 
causes no change in probability of release (p) whereas catechol caused a 
significant increase. 
Effect of catechol and dopamine upon endplate potentials in cut fiber muscle: 
The cut fiber preparation of Barstad and Lilleheil (19 58) was employed 
for the purpose suggested by the authors: "as an adjuvant tool in the study 
of the basic pharmacology and physiology of the myoneural junction. " 
Therefore, results obtained with this procedure will be compared to the 
results obtained with the d-Tc blocked preparation. 
-5 -Catechol (lxlO M) was added to the cut fiber preparation and evoked 
epps were recorded (Fig. 17). In five cats an increase of the epp amplitude 
" 
was always obtained. The enlarged endplate potentials did not demonstrate 
any measureable change in either the rise-time, half-fall or membrane 
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potential (Table 9). Very little difference can be not.ed between these 
results in the cut fiber and those previously reported in the d-Tc blocked 
muscle (Table 5). 
This is not the case, however when comparing the action of dopamine 
in the cut fiber (Table 10) with the action of dopamine in a d-Tc blocked 
\ 
preparation (Table 6). Figure 18 shows that dopamine like catechol 
(Fig. 17) greatly increases the size of evoked epps in the cut fiber pre-
paration. Unlike catechol, dopamine caused a significant decrease in the 
rise-time as well as in the half-fall of the epp. These latter decreases 
could suggest an increase in the rate of transmitter-receptor combination 
and/ or a decrease in the input resistance of the muscle membrane. Neither 
of these possibilities have been explored. 
One can also observe significant differences in the responses obtained 
with dopamine in the cut fiber vs. those obtained in the d-Tc blocked 
preparation (Tables 6 and 10). In the d-Tc preparation dopamine caused 
a deer~':_ of the epp which was paralleled in vivo by an exacerbation of 
a d-Tc induced paralysis. Dopamine in the cut fiber caused an increase of 
the epp which was paralleled in vivo by a slight facilitation of the 
contraction height in the indirectly stimulated tibialis anterior muscle. Thus 
" in vitro d-Tc may tend to block and thus to mask a facilitatory action of 
the drug. 
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A B 
Figure 17. F.pp recorded from a cut fiber Dreparation 
before (Panel A) and after (Panel B) lx10-SM catechol. 
The lower panel shows an action potential resulting 
from prolonged administration of the sa~e dose of 
catechol. The calibration signal in A and B is 
SmV x lmsec; in the lower panel it is SOmV x lmsec. 
" 
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EFFECTS 
CONTROL 
(N=4) 
TREATED 
(N=4) 
OF CATECHOL, 
Amplitude 
(mV) 
7.19 
+.98 
8.70* 
+.88 
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TABLE 9. 
1x10- 5M, ON 
Rise-time 
(msec) 
0.64 
+.20 
0.60 
+.14 
' \ 
E.P.P.s IN CUT 
Half-fall 
(msec) 
1.23 
+.23 
1.17 
+.21 
FIBER 
R.P. 
(mV) 
48.4 
+7.9 
48.4 
+8.9 
*The difference is statistically significant at p <.OS. 
Data pooled from four cats and expressed as mean + standard 
error. 
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Figure 18. Epp recorded from a cut fiber ~reparation 
before (Panel A) and after (Panel B) lxlo- M dopamine. 
The calibration signal is SmV x lmsec; 
EFFECTS OF DOPAMINE, 
CONTROL 
(N=3) 
TREATED 
(N=3) 
Amplitude 
(mV) 
10.67 
+2.55 
16.81* 
+S.54 
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TABLE 10. 
1x10- 5M, ON 
Rise-time 
(msec) 
0.54 
+.04 
0.45* 
+.06 
E.P.P.s IN CUT 
Half-fall 
(msec) 
1.42 
+.10 
1.30* 
+.18 
FIBER 
R.P. 
(mV) 
38.7 
+1.3 
37.3 
+1.3 
*The differences are statistically significant at p < . 05. 
Data pooled from three cats and expressed as mean + standard 
error. 
" 
r 114 
Effect of catechol and dopamine upon storage and release of transmitter in 
cut fiber muscle: ' 
In order to compare further the actions of a drug in d-Tc blocked 
preparations vs. cut fiber preparations catechol and dopamine were applied 
to cut fiber preparations stimulated at 200 /sec. The effect of catechol in the 
cut fiber is shown in Fig. 19 which depicts a representative set of epps 
before and after catechol. In this preparation a visible increase in the 
amplitude of all the epps of the head can be observed as well as a decrease 
in all of the epps of the tail. As can be seen from Tables 7 and 11 the data 
obtained with catechol in the cut fiber preparation, although quantitatively 
different from those obtained in the d-Tc treated preparations, show a 
similar trend. In the cut fiber only the quantal content of the first epp (M0), 
and probability of release (p) show a significant difference from control; 
these parameters were also affected by catechol in the d-Tc treated prepar-
ation. On the other hand, the quanta! size (q) in the cut fiber was not 
depressed by catechol as it was in the d-Tc preparations. Similarly, 
mobilization (dm) was not altered by catechol in the cut fiber whereas it was 
significantly increased in the d-Tc blocked preparation. 
Like catechol, results obtained with dopamine ·on epps recorded from 
cut fiber preparations stimulated at 200 I sec were different from those 
' obtained in d-Tc blocked preparations. Figure 20 shows the representative 
effects of dopamine on a train of epps. One can again see an increase in the 
~------------------------
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Figure 19. The first twelve and last ten epps recorded 
from a cut fiber preparation before (Panel A, top and 
bottom, respectively) and the first and last ten ep~s 
after (Panel B, top and bottom, respectively) lxlO- M 
catechol. Stimulus frequency = 200/sec. Calibration 
signal = SrnV. 
r 
CONTROL 
(N=7) 
TREATED 
(N=7) 
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TABLE 11. 
EFFECTS OF CATECHOL, lxlo-SM, ON STORAGE AND RELEASE 
OF TRANSMITTER IN CUT FIBER 
Mo (quanta) 
214.S 
+16.9 
31s.o** 
+29.0 
n 
(quanta) 
3028 
+477 
3128 
+844 
p 
(Mo/n) 
0.073 
+.017 
0.144* 
+.039 
q 
(mV) 
0.080 
+.020 
0.074 
+.026 
dm 
(quanta/msec) 
21.3 
+3.9 
21.6 
+3.6 
**The difference is statistically significant at p < .0005. 
*The difference is statistically significant at p <.OS. 
Data pooled from seven cats and expressed as mean + standard 
error. 
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A B 
Figure 20. The first and last thirty-four epps 
recorded from a cut fiber preparation before (Panel A, 
top and bottom, respectively) and after (Panel B, top 
and bottom, respectively) lx10-s~,1 dopamine. Stimulus 
frequency = 200/sec. Calibration signal = SmV. 
' 
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TABLE 12. 
EFFECTS OF DOPAMINE, lxlO-sM, ON STORAGE AND RELEASE 
OF TRANSMITTER IN CUT FIBER 
CONTROL 
(N=3) 
'FREATED 
(N=3) 
Mo (quanta) 
199.7 
+40.2 
302.2* 
+65.3 
n 
(quanta) 
2736 
+573 
3163 
+618 
p 
(Mo/n) 
0.073 
+.002 
0.108 
+.041 
q 
(mV) 
0.097 
+.026 
0.069* 
+.031 
dm 
(quanta/msec) 
16.3 
+3.2 
21.9 
+3.7 
*The differences are statistically significant at p <.OS. 
Data pooled from three cats and expressed as mean + standard 
error. 
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amplitude of the first few epps as well as a steeper run-off to a relatively 
steady-state in which the amplitude of the tail epps are slightly depressed 
compared to control epps. Similar data were obtained in three different 
cats and these data are summarized in Table 12. A significant increase is 
obtained in the quanta! content of the first epp {M0); the size of each 
quantum {q) was significantly decreased. Unlike catechol, dopamine did not 
cause a significant increase in the probability of release {p). Dopamine 
did cause a larger increase in mobilization {dm) and readily available stores 
{n) than did catechol in the cut fiber preparation. Dopamine in the cut 
fiber produces significant changes in the quanta! content of the first epp {M ) 
. 0 
and the quanta! size (q) which are not evident in the presence of d-Tc. D-Tc 
also acts to depress the increase in probability of release (p) caused by 
dopamine in the cut fiber preparation. The other parameters, n and dm, 
are affected by dopamine similarly in both the d-Tc preparation as well as 
the cut fiber preparation. 
Effect of catechol upon equilibrium potential and effective membrane 
resistance in cut fiber muscle: 
In a final effort to disclose a possible postsynaptic action for catechol 
at the neuromuscular junction n'\easurements of muscle input resistance 
and equilibrium potential were performed. Using the technique of Fatt and 
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Figure 21. The second tracing represents a control epp 
in a cut fiber preparation. Tracings 1, 3, 4, S, and 6 
are electrotonic potentials induced hy increasing cur-
rent pulses. In th~ middle of these electrotonic poten-
tials an epp has been evoked. The uppermost figure de-
monstrates a reversal of the epp with a depolarizing 
current pulse; the lower figures show the effects of 
hyperpolaring current pulses. The calibration signal 
is SmV x lmsec. 
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Katz (1951) it was possible to determine simultaneously these parameters. 
These experiments were conducted using the cut fiber preparation for two 
reasons. 1) Since the preparation is not complicated by other drugs a more 
accurate estimate of catechol' s effects on the input resistance or equilibrium 
potential should be obtained. 2) An accurate estimate of the equilibrium 
potential was necessary in using the computer analysis to determine a drug 
effect upon storage and release of transmitter. Prior to this, there has been 
no report of equilibrium potential values at mammalian neuromuscular 
junctions, so that this estimate was needed. As can be seen (Table 13), 
the resting potentials were low compared to the data of others on the cut 
fiber preparation. The 'normal' resting potential for a cut fiber preparation 
was reported as being in the range of -40 to -50 mV. However, the insertion 
of the second electrode usually will cause a drop of this resting potential 
(Fatt and Katz, 1951; Boyd and Martin, 1956b). 
A control epp and a series of electrotonic potentials with evoked end-
plate potentials are shown in Figure 21. Utilizing the electrotonic potential 
and current signals, the effect of catechol upon muscle input resistance was 
determined (cf. Methods). The results obtained from one of five animals 
is plotted in Figure 22. The individual points are not significantly different 
from each other in control and treated preparations. The mean values + 
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Figure 22. Effect of catechol, lx10-SM, on effective 
membrane resistance. The resistance was calculated 
from the electrotonic potential change produced by 
intracellularly applied hyperpolarizing currents. 
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standard error obtained in control and preparations treated with catechol 
-5 5 (lxlO M) were 3. 8 + O. 5xl0 and 4.1 + O. 8x10 5 , respectively. 
The equilibrium potential may be defined as that level of membrane 
potential at which the inward sodium current is equally and oppositely 
balanced by the outward potassium current. This results in an inability to 
\ 
produce an epp after supramaximal indirect stimulation. 
From the same experiments, an estimate of the equilibrium 
potential before and after cat echol was obtained. An example of the results 
collected from one of the five animals is plotted in Figure 23. Similar 
control values were recorded by Takeuchi and Takeuchi (1959) using a 
d-Tc blocked frog muscle preparation. Catechol (lxl0- 5M) did not 
significantly affect the normal equilibrium potential of the cut fiber 
preparation (Table 13). 
• 
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Figur~ 23. Effect of lx10-SM catechol on the equili-
brium potential of a cut fiber preparation. 
Control = -16mV. Treated = -14mV. 
' 
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TABLE 13. 
EFFECTS OF CATECHOL, lxl0- 5M, ON EXTRAPOLATED EQUILIBRIUM 
POTENTIAL IN CUT FIBER 
CAT I 
CAT II 
CAT III 
CAT IV 
CAT V 
MEAN 
+S.E. 
Control 
-mV 
10.0 
14.0 
16.0 
19.S 
13.S 
14.6 
+1.6 
Treated 
-mv 
13.5 
6.5 
13.S 
22.0 
10.0 
13.l 
+2.6 
Resting Potential 
-rnv 
20.0 
24.0 
24.0 
36.0 
22.0 
25.2 
+2.8 
The differences are not statistically significant. 
DISCUSSION 
' 
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d-Tc antagonism - in vivo 
The results obtained from in vivo studies with the cat anterior tibialis 
muscle demonstrate that catechol or phenol reverse the paralyzing action 
of d-Tc. These data support the earlier report of Mogey and Young 
(1949), who used the rat diaphragm. Prior treatment with alpha- or 
beta-adrenoreceptor blocking compounds did not alter the anti-d-Tc action of 
catechol or phenol. In contrast, epinephrine, although it initially appears to 
antagonize the d-Tc paralysis, causes a secondary depression and dopamine 
produces enhancement of the d-Tc blockade. Results with epinephrine 
support the work of Naess and Sirnes (1953); the d-Tc-like action of dopa-
mine was already reported by Blu.m (1969}. When an alpha-receptor blocking 
agent is given prior to d-Tc, the anti-d-Tc action of epinephrine is 
abolished (Maddock et al., 1948; Bowman and Raper, 1966; 1967). However, 
prior treatment with a beta-receptor blocking agent does not alter the 
anti-d-Tc action of epinephrine {Bowman and Raper, 1966). 
I should like to suggest on the basis of the relation between the 
structures of the four compounds, phenol, catechol, epinephrine and 
dopa.min€ (Fig. 4) and their anti-d-Tc action that the addition of the ethyl 
amine or ethanolamine side chain tends to decrease the presynaptic action 
and mask it with an overriding postsynaptic d-Tc-like action. 
I ~ 
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Anti-benzoquinonium action - in vivo 
Bowman (1958) reported that benzoquinonium acted as a competitive 
blocker at the neuromuscular junction, and that this action could be antago-
nized by epinephrine. Benzoquinonium was also demonstrated to prevent 
the facilitatory action of some anti-ChEs (Bowman, 1958; Blaber and 
Bowman, 1962; Christ and Blaber, 1968), especially those possessing a 
presynaptic facilitatory action (Blaber and Christ, 1967). Bowman and 
Blaber (1962) concluded that anti-ChE facilitatory drugs were unable to 
antagonize a benzoquinonium paralysis. That this was not due to the anti-
ChE effect of benzoquinonium was shown previously by Karczmar (19 61). 
In the present experiment, it was observed that the neuromuscular blockade 
. ' . 
produced by benzoquinonium could be antagonized by catechol or phenol; it 
can be concluded that catechol, phenol or epinephrine do not occupy the 
same presynaptic site as the anti-ChE-type of facilitatory drugs. 
Effects on maximum contractions - in vivo 
Catechol (2. 9%). phenol (9%) or dopamine (10%) had little facilitatory 
effect upon the indirectly stimulated muscle contraction. In contrast, 
epinephrine has been repeatedly shown to cause a significant facilitatory 
response on fast muscle and a ~epressant response on slow muscle (Bowman 
and Zaimis, 1958). Blum (1969) using the anterior tibialis muscle reported 
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that dopamine caused a high incidence of depressant action with a certain 
incidence of either no effect or a slight facilitation. Ferko and Calesnick 
(1971) using a different muscle, the gastrocnemius, reported a depressant 
action of dopamine. This latter response (Ferko and Calesnick, 1971) may 
be attributable to the presence of about 50% slow fibers in the gastrocnemius 
muscle. As in the case of the experiments of Blum (1969) dopamine was 
administered by Ferko and Calesnick (1971) in higher doses than I used; 
both investigators also employed an i. v. rather than the close-arterial 
route of administration. It might be possible that the responses obtained by 
these authors were due to a dopamine metabolite, rather than dopamine 
itself. Ferko and Calesnick (1971) were able to show a depressant effect 
with dopamine after prior treatment with either an alpha- or beta-receptor 
blocking compound. 
Neither catechol nor phenol produced a contraction of the muscle when 
injected close-arterially into the innervated or into the chronically or 
subacutely denervated muscle. In higher doses, however, both catechol 
and phenol produce a biphasic response consisting of a partial block and 
facilitation or else simply block. \Vhen a block was obtained, a contracture 
of the muscle could be recorded similar to that seen with appropriate doses 
of depolarizing or anticholinesterase agents. No fibrillations were ever 
recorded in chronically denervated muscles after the addition of either 
r ______________________ ~ 
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compound. It may be concluded from these results that catechol or phenol 
do not stimulate the muscle by a direct depolarizing action. 
Okamoto and Riker (1969) have proposed a technique of 48-hour 
denervation to evaluate selectively motor nerve terminal responsiveness. 
This preparation demonstrated a severe reduction in the ability to respond to 
repetitive stimulation but the single impulse transmission did not appear 
to be affected seriously. At 48 hours Okamoto and Riker also reported 
absence of denervation sensitization. Using this technique I could show that 
catechol or phenol were greatly reduced in their effectiveness to antagonize 
d-Tc. This suggested that the nerve terminal may be the site of drug 
action. This conclusion supports that of Otsuka and Nonomura (1963) who 
used the isolated frog sartorius muscle. 
Effects on responses to clos~arterially injected ACh 
Bowman and Raper (19 67) demonstrated that during the antagonism of 
d-Tc by epinephrine contractions resulting from close-arterial injections 
of acetylcholine are depressed throughout the whole effect of epinephrine. 
They concluded that the postsynaptic effect of epinephrine was to decrease 
the sensitivity of the muscle to ACh and that the anti-d-Tc action of 
epinephrine could best be explained via a presynaptic mechanism which 
would involve the increase in the quantity of ACh released per nerve impulse. 
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In this investigation, ACh responses were depressed during initial d-Tc 
reversal due to epinephrine; as the anti-d-Tc action ensued, the ACh 
contractions became normalized. It does not appear that catechol depresses 
or increases the responsiveness of the muscle membrane to A Ch. It can 
therefore be concluded that catechol neither "sensitizes" the receptor to the 
action of ACh, nor inhibits ChE (Blaber, 1963). 
Effects of blood flow 
Muscle blood flow recordings have shown that the effects of catechol-
amines on neuromuscular transmission are independent of the vascular 
changes produced (Bowman and Raper, 1966). Dopamine's depression of 
musc1e contractility was independent of blood flow changes as reported by 
Ferko and Calesnick (1971). From my results of blood flow measurement 
during the administration of catechol or phenol it appears that their action 
at the neuromuscular junction are also independent of the accompanied 
vaso constriction. 
Effects of drug combinations with neostigmine and aminophylline - in vivo 
Breckenridge et al. (1967) have concluded that epinephrine augments 
the contractions of unblocked muscle by a beta-receptor action which could 
be potentiated by neostigmine and aminophylline. As was pointed out by 
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Bowman and Nott (1969) the beta-receptor blocking drug used in their study, 
propranalol, which I used, has a strong local anesthetic action (Usubiaga, 
1968). Standaert and Roberts (1967) have shown that propranalol abolished 
postsynaptic repetitive firing in the cat soleus muscle and nerve by an 
action unrelated to blockade of beta-receptors, and a similar action may 
account for the observation that it abolished twitch potentiation produced by 
a co1nbination of neostigmine and epinephrine (cf. also Breckenridge et al., 
1967). I have repeated these experiments and have obtained similar results 
to those reported by Breckenridge et al. (1967); I feel however that another 
beta-receptor blocking compound should be examined, such as MJ 1999. 
Propranalol does not effect the potentiating action of aminophylline as 
evidenced by prior administration to combinations of aminophylline + catechol 
+neostigmine or aminophylline +phenol + neostigmine (Table 2). Similarly, 
prior administration of phenoi.:ybenzamine does not alter the potentiating 
action of aminophylline + catechol + neostigmine or aminophylline + phenol 
+ neostigmine (Table 2). 
Conclusions from in vivo studies 
From these in vivo studies I have concluded that there is some 
evidence suggesting a difference in the mode of action of anti-ChEs, 
epinephrine, dopamine and catechol or phenol. .~11 of the compounds except 
dopamine antagonize a d-Tc paralysis. Anti-ChEs and catechol or phenol 
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will reverse a d-Tc paralysis in the presence of an alpha-adrenoceptor 
blocking agent. Catechol or phenol and epinephrine will antagonize a 
benzoquinonium block; anti-ChEs will do it only to a limited degree 
(Karczmar, 1961). All of the compounds will facilitate muscle contraction, 
epinephrine being the most potent. Epinephrine, catechol or phenol do not 
increase the responses to close-arterially injected ACh whereas anti-ChEs 
increase this response. Aminophylline with catechol or phenol + 
neostigmine combinations still potentiate muscle contractions after pre-
treatment with either an alpha- or beta-receptor blocking agent whereas 
these blockers attenuate significantly. the ability of aminophylline with 
epinephrine + neostigmine combinations to potentiate muscle contractions. 
Finally, it appears that both catechol and phenol act via the same mechanism 
and at the same site. In all instances when both compounds - catechol and 
phenol - were tested parallel results were obtained. The only difference 
that was noted was that of potency (catechol 5x phenol). 
With this evidence as the background, electrophysiological studies were 
began in ~itro to elucidate the precise site, as well as, the mechanism of 
action of catechol and phenol. It should always be kept in mind that the 
purpose of this investigation was to gain insight into the facilitatory action 
of the catecholamines at the neuromuscular junction. Since the results 
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obtained with either catechol or phenol differ only as to the potency of each, 
it was decided to continue the study using only catechol and compare its 
actions in vitro to chemically the most similar and simplest catecholamine, 
dopamine (Fig. 4). 
Effects upon mepps - in vitro 
Katz (1962) concluded that since mepps are of a presynaptic origin, 
their frequency can only reflect pre synaptic events. In the in vitro 
preparation treated with various doses of catechol a statistically significant 
increase in mepp frequency was observed ~ndicating a presynaptic site of 
action. Kuba (1969) observed a large increase in mepp frequency with 
phenol at the fish neuromuscular junction. 
Changes in the amplitude of mepps may reflect both pre- and post-
synaptic factors. Since catechol did not change the amplitude of mepps it 
was concluded that it must have only a presynaptic site of action. However, 
very few compounds act only at one site so that a postsynaptic site of a~tion 
was further examined. In measuring mepp amplitude, individual mepps were 
also analyzed for changes in time course, i.e. rise-time and half-fall. 
None could be found. There have been reports (Krnjevic and Miledi, 1958; 
Jenkinson, Stamenovic, and Whitaker, 1968; and Kuba, 1971) that catechol-
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amines which activate the alpha-receptor increased the frequency of mepps, 
while catecholamines which activate the beta-receptor increase both the 
frequency and amplitudes of mepps. Thus on the basis of mepp analysis 
it appears that catechol is si~ilar to the alpha-receptor activators in 
having a presynaptic action and that it differs from the beta-receptor 
activators as it does not augment the amplitude of mepps. 
Effects on epps in d-T c 
Catechol increases the amplitude of epps recorded in the presence of 
d-Tc, without changing their time course. It also does not change the 
recorded resting membrane potential. These results confirm the reports of 
Otsuka and Nonomura (1963) at the frog neuromuscular junction, and 
resemble the results obtained with phenol by Kuba (1969) at the fish neuro-
muscular junction. All these authors concluded that this augmentation of the 
epp amplitude was due to an increase in the release of transmitter released 
from the nerve endings. They further rule out the possibilities that phenol 
or catechol might either have anti-ChE activity or else sensitize the post-
synaptic membrane to ACh; indeed, they did not show any change in the 
configuration of the ACh potential in the presence of catechol (Otsuka and 
Nonomura, 1953) or phenol (Otsuka and Nonomura, 1963; Kuba, 1969). 
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Hutter and Loewenstein (1955), Krnjevic and Miledi (1958), Jenkinson et al. 
(1968) and Kuba (1970) demonstrated that epinephrine or norepinephrine 
increased the amplitudes of epps recorded in the presence of d-Tc or high 
concentrations of magnesium. Jenkinson et al. (1968) and Kuba (1970) suggest 
that the increased amplitude of epps recorded in the presence of epinephrine 
or norepinephrine is due to an action at a presynaptic alpha-adrenoceptor. 
Supporting evidence included the ability to inhibit this facilitatory action with 
an alpha-receptor blocking agent. Results with dopamine show either no 
effect or a slight depressant action upon the amplitude of epps recorded in 
d-Tc; the half-fall was slightly prolonged. This effect upon the half-fall 
may be attributed to an alteration in the passive membrane properties, eg. 
resistance, or the drug may desensitize the membrane to ACh. Kuba (1969) 
has demonstrated that phenol does not modify the input resistance of the 
postsynaptic membrane. However, catecholamines which activate the beta-
receptor increase the membrane resistance (Kuba, 1970). 
Kuba (1970) demonstrated that epinephrine and isoproterenol caused a 
significant increase in the resting potential; norepinephrine did not. On the 
other hand, Christ and Nishi (1971) reported that epinephrine did not hyper-
polarize the postsynaptic membrane of the rabbit cervical ganglion. They 
demonstrated that epinephrine decreased the frequency of miniature excita-
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" tory postsynaptic potentials (this latter action being antagonized by the alpha-
receptor blocking agents, phenoxybenzamine or dihydroergotamine). Libet 
(1970) has proposed that dopamine is the catecholamine transmitter respon-
sible for activation of the inhibitory cholinoceptive site of the ganglion 
resulting in hyperpolarization. 
I should like to suggest that the addition of the ethanolamine side chain 
acts to change the basic catechol action in a d-Tc preparation from one of 
facilitation at the nerve terminal to a mixed action; depression predominated 
over the facilitation when the side chain is reduced to ethylamine. There 
also appears to be a shift to a postsynaptic site of action which tends to 
mask the underlying presynaptic site. 
Effects on storage and release of transmitter in d-Tc 
In an effort to define better the site and mechanism of catechol's 
anti-d-Tc effect, trains of epps were analyzed for transmitter release 
phenomena - quantal content of the first epp (M0), readily releasable stores 
(n), probability of release (p), quantal size (q), and mobilization (dm). 
Catechol (Table 7) significantly increased all the par:ameters analyzed with 
the exception of readily available stores (n) and quantal size (q). These 
results support the conclusion of Otsuka and Nonomura (1963) in their 
experiments with catechol and phenol, and also the conclusion of Kuba (1969) 
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in his experiments with phenol, that these agents cause an increase in the 
probability of release of transmitter. The increased quantal content of the 
first epp of the trains follows from the increased probability of release (p), 
i.e. is due to the amount of quanta/impulse. My data also supports the sug-
gestion made by Otsuka and Nonomura (1953) that phenolic compounds do not 
change the amount of the store of available transmitter. This combination of 
action, an increased probability of release and little change in the amount of 
the store of available transmitter may explain the observed decrease in the 
amplitude of the tail epps after catechol. In this context, it should be 
emphasized that Potter (1968) demonstrated that the newly formed trans-
mitter is the first to be released on demand. Thus, a "younger" quantum 
that is forced to be released may not contain the same amount of trans-
mitter as a more "mature" quantum. 
In the case of dopamine in d-Tc preparations there is no significant 
change in any of the storage and release parameters (Table 8). Although the 
probability of release remains constant, the readily available stores tend to 
increase; this is similar to the effect observed after catechol. This 
increase in n may account for the observed increase· in quantal content after 
dopamine. The decrease in quanta! size could be explained by a post-
synaptic d-Tc-like action rather than by an increased probability of 
release without a sufficient increase in mobilization which was suggested 
for catechol. It appears that the addition of the side chain to the catechol 
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nucleus tends to decrease the facilitatory action of these compounds. 
Effects on epps in cut fiber muscle 
The final series of experiments were employed to examine catechol's 
and dopamine's effect upon neuromuscular transmission in the absence of 
\ 
d-Tc. It has been suggested that since d-Tc not only has a powerful post-
synaptic action but also a weak presynaptic action as well, its presence in 
the control solution does not really yield "control" results. The same 
should also be noted for experiments done in the presence of Ringer 
solutions containing high magnesium concentrations. 
In cut ~iber preparations catechol produced a significant increase in 
the amplitude of epps without changing their time course. It did not 
change the recorded resting membrane potentials. Thus far these results 
mirror those observed in the presence of d-Tc. 
Dopamine also produced a significant increase in epps recorded with 
the cut fiber preparation, but this facilitation was complicated by the change 
in the time course of these epps. Dopamine did not change the recorded 
resting potentials. 
Effects on storage and release of transmitter in cut fiber muscle 
Upon examination of trains of epps in the cut fiber preparation a 
slightly different picture emerges as compared to the results obtained with 
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the d-Tc blocked preparation. In the cut fiber experiments the only signifi-
cant changes observed were increases in the quanta! content of the first 
endplate potential {Mo) and an increase in the probability of release {p). 
The other parameters {n, q, dm) all remain more or less constant {Table ll). 
The fact that there is no change in the quantum size mirror~ the results 
obtained with mepps wherein no change in amplitude was observed after the 
addition of the drug. It should be noted that the values obtained for the 
probability of release in both control and treated preparations are below 
the values of the "control", i.e. the d-Tc blocked preparation, while the 
values for mobilization are well above comparable values obtained in the 
d-Tc blocked preparation. These parameters indicate that indeed 
d-tubocurarine has a presynaptic action that is apparently facilitatory in 
effect. Actually, the high increase in probability of release as well as the 
low rate of mobilization tend to add to the classical postsynaptic blocking 
action of d-Tc. Catechol, therefore, tends to have a more significant 
role in the presence of d-Tc than it does in its absence. This latter effect 
in fact corresponds to the effects of catechol obtained in vivo. 
In the case of dopamine in the cut fiber prepar·ation {Table 12), one 
observes an increase in the quanta! content of the first epp {M0); as in the 
d-Tc blocked preparation this may be due to the slight increase in the 
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amount of readily available stores (n). Unlike with d-Tc treated 
preparations, one can observe in the cut fiber preparation a slight increase 
in the probability of release (p) as well as in the rate of mobilization (dm). 
There is a significant decrease in the size of each quantum (q) which may 
be due to dopamine's "curaremimetic" action as observed in the d-Tc 
blocked muscle. An alternative explanation for this depression in quantal 
size may be similar to that suggested for catechol; i. e. the depression may 
be due to an increased 'p' leading to an increased quanta! content of the 
first epp (M
0
) without a sufficient concomitant increase in the readily 
available store. The net result would be a utilization of less "mature" 
quanta. In either case, the cut fiber data tends to e;xpose actions of these 
compounds at the neuromuscular junction which may be masked by the 
presence of d-Tc. 
Once again, catechol, per se, appears to have a pure presynaptic 
facilitatory action while the compounds with an added ethanolamine or ethyl 
amine side chain possess a stronger postsynaptic action which tends to 
override any presynaptic facilitatory effects. 
Effects on equilibrium potential and effective membrane resistance 
A final series of experiments was conducted to ascertain possible 
catechol induced changes in the passive membrane properties as well as 
the equilibrium potential of the muscle. These experiments were 
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conducted using the cut fiber preparation in order to avoid any complications 
that might arise due to the presence of d-Tc. Similar to the results of Kuba 
(1969) using phenol at the slow fish muscle not treated with d-Tc, catechol 
did not cause a change in input resistance of the muscle fiber. Likewise, 
I was not able to demonstrate any significant alteration by catechol of 
the equilibrium potential measurements. Kuba (1970) has demonstrated 
that alpha-receptor stimulating catecholamines do not cause a change in the 
passive membrane properties of the rat diaphragm; the catecholamines 
which stimulate the beta-receptor cause an increase in the membrane 
resistance. This latter effect on the other hand might account for the 
slight prolongation that was recorded in the half-fall of epps with dopamine. 
Might it be that in certain muscle diseases this particular 
potential level (the quilibrium potential) is affected such that normal 
propagation is inhibited? 
Possible applications 
Facilitatory drugs other than anti-ChEs have been used clinically with 
little success. This deficiency has been primarily ~ue to the lack of 
availability of a drug which at a specific site possesses a potent facilitatory 
action. As mentioned earlier, "A drug that is active at one site acts to 
some degree at all other sites ... " (Karczmar and Blaber, 1967). 
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Cat~chol may serve as a useful tool in the develol_)ment of a specific 
potent facilitatory drug. An example of an application for such a compound 
would be in myasthenia gravis. A compound if not sufficiently potent 
of itself could be administered in combination with synergistic agents. 
Using ca.techol as an example such a combination could involve the anti-ChE, 
neostigmine, and the methylxanthine, aminophylline. These drug combin-
ations would then allow a lower dose of each to be used, resulting in an 
enhanced therapeutic effect with minimal untoward effects. This 
speculation is being tested clinically in our laboratories. 
CONCLUSION 
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The facilitatory action of catechol and phenol was investigated using the 
cat anterior tibialis muscle preparation. Catechol was further investigated 
at the cat tenuissimus muscle utilizing standard microelectrode techniques. 
Analysis of data from these experiments has resulted in the ·following 
conclusions: 
l} Catechol or phenol will antagonize a d-tubocurarine paralysis by a 
mechanism that is not affected by either alpha- or beta- adrenoreceptor 
blocking agents. 
2) Both compounds antagonize a benzoquinonium paralysis. 
3) In doses which reverse either a d-tubocurarine or benzoquinonium 
paralysis, catechol or phenol do not have a direct action on the muscle fiber. 
4) Neither agent sensitizes post-junctional receptors to acetylcholine or 
inhibits acetylcholinesterase. 
5) Catechol and phenol act at a common site via a common mechanism. 
6} Catechol will increase the frequency of miniature endplate potentials 
without altering their time course. 
7) The amplitude of endplate potentials are increased by catechol either in a 
muscle blocked with d-tubocurarine or in a cut fiber muscle. 
8) In the presence of d-tubocurarine, catechol caused a significant increase 
in the probability of release, the quantal content of the first endplate poten-
tial and the mobilization rate. 
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9) In the cut fiber preparation, catechol caused a significant increase in the 
probability of release and the quanta! content of the first endplate potential. 
10) Neither the normal input resistance nor the equilibrium potential are 
affected by catechol. 
11) The facilitatory action of catechol or phenol could only be assigned to 
a presynaptic site of action. A possible mechanism whereby this 
facilitatory action occurs has been suggested. 
\ 
BIBLIOGRAPHY 
148 
Adrian, E. D. (1925). The spread of activity in the t~nuissimus muscle of 
the cat and in other complex muscles, J. Physiol. 
(London), 60, 301-315. 
Ahlquist, R. P. (1948). A study of adrenotropic receptors, Am. J. Physiol. 
153, 586-600. 
Angel, A., Lemon, R. N., Robers, K. J., Banks, P. (1969). The effect of 
polyhydroxyphenols on brain ATP in the mouse, Exp. 
Brain Res., 7, 250-257. 
Auerbach, A. and Betz, W. (1971). Does curare effect transmitter release? 
J. Physiol. (London), 213, 691-706. 
Axelrod, J. , In: Ciba Foundations on Adrenergic Mechanisms, Churchill, 
London, pp. 28-39 (1960). 
Axelrod, J. and Tomchik, R. (1958). Enzymatic o-methylation of 
epinephrine and other catechols, J. Biol. Chem., 233, 
702-705. 
Bacq, Z. M. (1949). Metabolism of adrenalin, Pharmacol. Rev., 1, 1-26. 
Bacq, Z. M. and Brown, G. L. (1937). Pharmacological experiments on 
mammalian voluntary muscle, in relation to the theory of 
chemical transmission, J. Physiol. (London), 89, 45-60. 
Bacq, Z. M., Gosselin, L., Dresse, A. and Renson, J. (1959). Inhibition of 
0-methyltransferase by catechol and sensitization of 
epinephrine, Science, 130, 453. 
Barger, G. and Dale, H. H. (1910). Chemical structure and sympatho-
mimetic action of amines, J. Physiol. (London), 41, 
19-59. 
Barnett, R. <T. (1962). The fine ultrastructural localization of acetyl-
cholinesterase at the nyoneural junction, J. Cell Biol. , 
12' 247-262. 
Barstad, J. A. B. and Lilleheil, G. (1968). Transversally cut diaphragm 
preparation from rat, Arch. Int. Pharmacodyn. Ther., 
175, 373-390. 
--- .... - 1"91'1 
149 
Bass, L. and Moore, W. J. (1966). Electrokinetic m~chanism of miniature 
postsynaptic potentials, Proc. Nat. Acad. Sci., 55, 
1214-1217. 
Beani, L., Bianchi, C., and Ledda, F. (1964). The effect of d-tubocurarine 
on acetylcholine release from nerve terminals, J. 
Physiol. (London), 174, 172-183. 
Bennett, H. S. (1956). The concepts of membrane flow and membrane 
vesiculation as mechanisms for active transport and ion 
pumping, J. Biophys. Biochem. Cytol., ~, Suppl. 99-103. 
Beranek, R. and Vyskocil, F. (1967). The action of tubocurarine and atro-
pine on the normal and denervated rat diaphragm, J. 
Physiol. (London), 188, 53-66. 
Bernard, C.R. (1851). Action de curare et de la nicotine sur le systeme 
nerveux et sur le systeme musculaire, Compt. Rend. 
Soc. Biolog. Paris, ~' 195. 
Birks, R. I. (1963). The role of sodium ions in the metabolism of acetyl-
choline, Can .. J. Biochem. Physiol., 41, 2573-2579. 
Birks, R. I., Burstyn, P. G. R. and Firth, D.R. (1968). The form of sodium-
calcium competition at the frog myoneural junction, 
J. Gen. Physiol., 52, 887-907. 
Birks, R. I. and Cohen, M. W., Effects of sodium pump inhibitors on 
myoneural transmission in the frog, In: Symposium on 
Muscle, Edit. by W. M. Paul, E. E. Daniel, C. M. Kay 
and Q Manckton, Academic Press, New York, (1965) 
Birks, R. I. and Macintosh, F. C. (1957). Acetylcholine metabolism at nerve 
endings, Brit. Med. Bull., 13, 157-161. 
Birks,· R. I. and Macintosh, F. C. (1961). Acetylcholine metabolism of a 
sympathetic ganglion, Canad. J. Bio chem. Physiol. , 3 9, 
787-827. 
Blaber, L. C. (1960). The antagonism of muscle relaxants by ambenonium 
and methoxyambenonium in the cat, Brit. J. Pharmacol. 
Chemother., 15, 476-484. 
150 
Blaber, L. C. (1963). Facilitation of neuromuscular transmission by anti-
cholinesterase drugs, Brit. J. Pharmacol. Chemother., 
20, 63-73. 
Blaber, L. C. (1970). The effect of facilitatory concentrations of 
decamethonium on the storage and release of transmitter 
at the neuromuscular junction of the cat, J. Pharmacol. 
Exp. Ther., 175, 664-672. 
Blaber, L. C. and Christ, D. D. (1967). The action of facilitatory drugs on 
the isolated tenuissimus muscle of the cat, Int. J. 
Neuropharmacol., §_, 473-484. 
Blaber, L. C. and Goode, J. W. (1968). A comparison of the action of 
facilitatory and depolarizing drugs at the mammalian 
motor nerve terminal, Int. J. Nueropharmacol. , 7, 
429-440. 
Blaber, L. C. and Karczmar, A.G. (1967). Multiple cholinoceptive and 
related sites at the neuromuscular junction, Ann. N. Y. 
Acad. Sci., 144, 571-583. 
Blaber, L. C. and Karczmar, A.G. (1967). Interaction between facilitatory 
and depolarizing drugs at the neuromyal junction of the 
cat, J. Pharmacol. Exp. Ther., 156, 55-62. 
Blackman, J. G., Ginsborg, B. L. and Ray, C. (1963). On the quantal 
release of the transmitter at a sympathetic synapse, 
J. Physiol. (London), 167, 402-415. 
Bloedel, J., Gage, P.W., Llinas, P. andQuastel, D.M.J. (1966). Trans-
mitter release at the squid giant synapse in the pre~ence 
of tetrodotoxin, Nature, 212, 49-50. 
Blum, K. ,(1969). The effect of dopamine and other ~atecholamines on 
neuromuscular transmission, Arch. Int. Pharmacodyn. , 
181, 297-306. 
Bowman, W. C. (1958). The neuromuscular blocking action of benzoquin-
onium in the cat and in the hen, Brit. J. Pharmacol. 
Chemother., 13, 521-530. 
Bowman, W. C. (1959). A comparison between the vascular responses to 
adrenaline and noradrenaline in individual skeletal 
151 
muscles of the cat. J. Pharm. Pharmacol. , ll, 
104-119. 
Bowman, W. C., Mechanisms of neuromuscular blockade, In: Progress in 
Medicinal Chemistry, Edit. G. P. Ellis and G. B. West, 
\ Butterworth, London, pp. 88-131, (1962). 
Bowman, W. C., In: Evaluation of Drug Activities: Pharmacometrics, Edit. 
D.R. Laurence and A. L. Bachrach, Academic Press, 
London, 1, 325-351, (1964). 
Bowman, W. C. (1959) The effect of muscle contractions on the blood flow 
and the vascular responses to adrenaline, noreadrenaline 
and isoprenaline in individual skeletal muscles of the cat, 
J. Pharm. Pharmacol., 11, 641-649. 
Bowman, W. C., Goldberg, A. A. J. and Raper, C. (1962). A comparison 
between the effects of a tetanus and the effects of 
sympathomimetic amines on fast- and slow-contracting 
mammalian muscles, Brit. J. Pharmacol. Chemother., 
19, 464-484. 
Bowman, W. C. and Nott, M. W. (1969). Actions of sympathomimetic amines 
and their antagonists on skeletal muscle. Pharmacol. 
Rev. 21, 27-72. 
Bowman, W. C. and Rand, M. J. (19 61) Actions of Triethycholine on 
neuromuscular transmission. Brit. J. Pharmacol. 
Chemother., 17, 176-195. 
Bowman, W. C. and Raper, C. (1966). Effects of sympathomimetic amines 
on neuromuscular transmission, Brit. J. Pharmacol. 
Chemother., 27, 313-331. 
Bowman, W. C. and Raper, C. (1967). Adrenotropic: receptors in skeletal 
muscle, Ann. N. Y. Acad. Sci., 139, 741-753. 
Bowman, W. C. and Zaimis, E. (1956). The similarity in the response of 
skeletal, smooth and cardiac muscle to sympatho-
mirnetic amines, Communication to January Meeting of 
British Pharmacological Society. 
152 
Bowman, \V. C. and Zaimis, E. (1958). The effects of adrenaline, nor-
adrenaline, and isoprenaline on skeletal muscle 
contractions in the cat, J. Physiol. (London), 144, 
92-107. 
Boyd, I. A. (1956). The tenuissimus muscle of the cat, J. Physiol. (London), 
133, 35-36P. 
Boyd, I. A. and Martin, A. R. (1955). The quantal composition of the 
mammalian endplate potential, J. Physiol. (London), 
129, 14-15P 
Boyd, I. A. and Martin, A. R. (1956a). Spontaneous subthreshold activity at 
mammalian neuromuscular junctions, J. Physiol. 
(London), 132, 61-73. 
Boyd, I. A. and Martin, A. R. (1956b). The endplate potential in mammalian 
muscle, J. Physiol. (London), 132, 74-91. 
Boyd, I.A. and Martin, A.R. (1959). Membrane constants of mammalian 
muscle fibers, J. Physiol. (London), 147, 450-457. 
Breckenridge, B. McL., Burn, J. H. and Matschinsky, F. M. (1967). 
Theophylline, epinephrine, and neostigmine facilitation 
of neuromuscular transmission, Proc. Nat. Acad. Sci. , 
57, 1893-1897. 
Brooks, V. B. (1956). An intracellular study of the action of repetitive 
nerve volleys and of botulinum toxin in miniature 
endplate potentials, J. Physiol. (London), 134, 264-277. 
Brown, Byron, Wm. , (1962). Estimation of the mean number of quanta per 
en.dplate potential, J. Pharmacol. Exp. Ther., 138, 
327-328. 
Brown, G. L. (1938). The preparation of the tibialis. anterior muscle (cat) 
for close arterial injections, J. Physiol. (London), 92, 
22-23P. 
Brown, G. L., Bulbring, E. and Burns, B. D. (1948). The action of 
epinephrine on mammalian skeletal muscle, J. Physiol. 
(London), 107, 115-128. 
··-
153 
Brown, G. L., Dale, H. H., and Feldberg, W. J. (1936). Reactions of the 
normal mammalian muscle to acetylcholine and to eserine, 
J. Physiol. (London), 87, 394-424. 
Brown, G. L., Goffart, M. and Vianna, Dias, M. (1950). The effects of 
epinephrine and sympathetic stimulation on the demar-
cation potential of mammalian skeletal muscle, J. 
Physiol. (London), 111, 184--194. 
Brown, T. Graham, (1913). Tenuissimus muscle of cat in situ twitch 
response, Proc. Roy. Soc. London B~ 87, 132-144. 
Bulbring, E. and Burn, J. H. (1940). The effect of sympathomimetic amines 
and other substances on the contraction of skeletal 
muscle, J. Pharmacol. Exp. Ther., 68, 150-172. 
Bulbring, E. and Burn, J. H. ·(1942). The interrelation of prostigmine, 
adrenaline and ephedrine in skeletal muscle, J. PhysioL 
(London), 101, 224-235. 
Buller, A. J., Eccles, J.C. and Eccles, R. M. (1960). Differentiation of 
fast and slow muscles in the cat hind limb, J. Physiol. 
(London), 150, 399-416. 
Burke, W. (1957). Spontaneous potentials in slow muscle fibers of the frog, 
J. Physiol. (London), 135, 511-521. 
Changeux, J.P., Kasai, M., Lee, C. Y. (1970). Use of snake venom toxin 
to characterize the cholinergic receptor protein, Proc. 
Nat. Acad. Sci., 67, 1241-1247. 
Christ, D. D. and Blaber, L. C. (1968). The actions of benzoquinonium in the 
isolated cat tenuissimus muscle, J. Pharmacol. Exp. 
Ther., 160, 159-165. 
Christ, D. D. and Nishi, S. (1971). Site of adrenaline blockade in the 
superior cervical ganglion of the rabbit, J. Physiol. 
(London), 213, 107-117. 
Ciani, S. and Edwards, C. (1963). The effect of acetylcholine on neuro-
muscular transmission in the frog, J. Pharmacol. 
Exp. Ther., 142, 21-23. 
154 
Coers, C. (1955). Les variations structurelles normales et pathologiques 
de la junction neuromusculaire, Acta Neurol. Belg., 
55, 741-866. 
Coers, C. and Woolf, A. L., The Innervation of Muscles, Charles C. 
Thomas, Springfield, Ill., (1959). 
Cole, K. S. (1961). An analysis of the membrane potential along a clamped 
squid axon, Biophys. J., ~ 401-418. 
Collier, B. (1969). The preferential release of newly synthesized trans-
mitter by a sympathetic ganglion, J. Physiol. (London), 
205, 341-369. 
Collier, B. and Macintosh, F.C. (1969). The source of choline for acetyl-
choline synthesis in a sympathetic ganglion, Canad. J. 
Physiol. Pharmacol., 47, 127-135. 
Colomo, F. and Rahaminoff, R. (1968). Interaction between sodium and 
calcium ions in the process of transmitter release at the 
neuromuscular junction, J. Physiol. (London), 19 8, 
203-218. 
Cooper, S. (1929). The relation of active to inactive fibers in fractional 
contraction of muscle, J Physiol. (London), 67, 1-13. 
Coppee, G. (1943). La transmission neuromusculaire: curarisation, 
decurarisation et reinforcement a la junction myoneurale, 
Arch. Int. Physiol., 53, 327-507. 
Cori, C. F. (1931). Mammalian carbohydrate metabolism, Physiol. Rev., 
11, 143-27 5. 
Couteaux, R. (1958). Morphological and cytochemical observations on the 
post-synaptic membrane at motor endplates and 
ganglionic synapses, Exp. Cell Res., Suppl. ~· 294-322. 
Crouch, J.E., Text-atlas of Cat Anatomy, Lea and Febiger, Philadelphia, 
(1969). 
Csilik, B. Functional structure of the post-synaptic membrane in the 
myoneural junction, Akademiai Kiada, Budapest, pg. 41, 
(1967). 
155 
Curtis, D.R. and Eccles, J.C. (1960). Synaptic action during and after 
repetitive stimulation, J. Physiol. (London), 150, 
374-398. 
Dakin, H. D. (1905). On the physiological activity of substances indirectly 
related to adrenaline, Proc. Hoy. Soc. London B., 76, 
498-503. 
Dale, H. H. and Dudley, H. W. (1929). The presence of histamine and ace-
tylcholine in the spleen of the ox and the horse, J. Physiol 
(London), 68, 97-123. 
Dale, H. H. (1914). The action of certain esters and ethers of choline and 
their relation to muscarine, J. Pharmacol. Exp. Ther., 
6, 147-190. 
Dale, H. H., Feldberg, W. and Vogt, M. (1936). Release of acetylcholine 
at voluntary motor nerve endings, J. Physiol. (London), 
86, 353-380. 
deGroat, W. C. and Volle, R. L. (1965). Ganglionic actions of catechol-
amines, Pharmacologist, '!.._, 158. 
deHarven, E. and Coers, C. (1959). Electron microscopic study of the 
human neuromuscular junction, J. Biophys. Biochem. 
Cytol. , ~· 7-10. 
del Castillo, J. and Engback, L. (1954). The nature of neuromuscular block 
produced by magnesium, J. Physiol. (London), 124, 
370-384. 
del Castillo, J. and Katz, B. (1954a). Quanta! components of the endplate 
potential, J. Physiol. (London), 124, 560-573. 
del Castillo, J. and Katz, B. (1954b). Statistical fac~ors involved in neuro-
muscular facilitation and depression, J. Physiol. 
(London), 124, 574-585. 
del Castillo, J. and Katz, B. (1954c). Changes in endplate activity produced 
by presynaptic polarization, J. Physiol. (London), 124, 
586-604. 
156 
del Castillo, J. and Katz, B. (1957). A study of curare action with an 
electrical micro method, Proc. Roy. Soc. 
London B., 146, 339-356. 
del Castillo, J. and Stark, L. (1952). The effect of calcium ions on the 
motor endplate potentials, J. Physiol. (London), 116, 
507-515. 
Denny-Brown, D. E. (1929). The histological features of striped muscle in 
relation to its functional activity, Proc. Roy. Soc. 
London B., 104, 371-411. 
de Robertis, E. (1958). Submicroscopic morphology and function of the 
synapse, Exp. Cell Res. Suppl. ~, 347-369. 
de Robertis, E. (1971). Molecular biology of synaptic receptors, Science, 
171, 963-971. 
de Robertis, E. and Bennett, H. S. (1955). Some features of the submicro-
scopic morphology of synapses in frog and earthworm 
J. Biophys. Biochem. Cytol., _!, 47-58. 
Desmedt, J.E. (1966). Presynaptic mechanisms in myasthenia gravis, Ann. 
N. Y. Acad. Sci., 135, 209-246. 
Dodge, F.A.Jr. andRahaminoff, R. (1967). Ontherelationshipbetween 
calcium ion concentration and the amplitude of the 
endplate potential, J. Physiol. (London), 189, 90-91P. 
Dodge, F. A. Jr. and Rahaminoff, R. (1967). Co-operative action of calcium 
ion in transmitter release at the neuromuscular junction, 
J. Physiol. (London), 193, 419-432. 
Dubin, H. E. (1925). The effect of L-suprarenin (synthetic epinephrine) and 
various derivatives upon the bloo_d sugar of normal 
animals, J. Pharmacol. Exp. Ther., ~, 233-241. 
Dudel, J. and Kuffler, S. W. (1961). The quanta! nature of transmission and 
spontaneous miniature potentials at the crayfish neuro-
muscular junction, J. Physiol. (London), 155, 514-529. 
Eccles, J.C., The Physiology of Synapses, Springer-Verlag, Berlin; 
Academic Press Inc., New York, (1964). 
157 
Edwards, C. and Ikeda, K. (1962). Effects of 2-PA¥ and succinylcholine 
in neuromuscular transmission in the frog, J. Pharmacol. 
Exp. Ther., 138, 322-328. 
Elliott, T. R. (1905.). The action of adrenalin, J. Physiol. (London). 32, 
401-467. 
Ellis, S. (1958). Relation of biochemical effects of epinephrine to its 
muscular effects, Pharmacol. Rev., 11, 469-479. 
Ellis, S. and Vincent, N. H. (1966). Effect of ionic alterations in epinephrine 
induced cardiac glycogenolysis and phosphorylase 
activation, Pharmacologist, ~_. 185. 
Elmqvist, D., Johns, T. R. and Thesleff, S. (1960). A study of some electro 
physiological properties of human intercostal muscle, 
J. Physiol. (London), 154, 602 -607. 
Elmqvist, D. and Quastel, D. M. J. (1965). A quantitative study of endplate 
potentials in isolated human muscle, J. Physiol. (London), 
178, 505-529. 
Emmelin, N. and Macintosh, F. C. (19 56). The release of acetylcholine from 
perfused sympathetic ganglia and skeletal muscle, J. 
Physiol. (London), 131, 477-496. 
Fatt, P. and Katz, B. (1950). Some observations on biological noise, Nature, 
166, 597-598. 
Fatt, P. and Katz, B. (1951). An analysis of the endplate potential recorded 
with an intracellular electrode, J. Physiol. (London), 
115, 320-370. 
Fatt, P. and Katz, B. (1952). Spontaneous subthreshold activity at motor 
nerve endings, J. Physiol. (Lon~on), 117, 109-128. 
Feldman, D.S. (1965). Calcium dependence of spontaneous acetylcholine 
release at mammalian motor nerve terminals, J. Physiol. 
(London), 179, 33-34P. 
Feng, T. P. (19 3 6). Studies on the neuromuscular junction. I. The inhibition 
at the neuromuscular junction, Chin. J. Physiol., 10, 
417-434. 
158 
Feng, T. P. (1936) Studies on the neuromuscular junction. II. The universal 
antagonism between calcium and curarizing agencies, 
Chin. J. Physiol. , 10, 513 - 52 8. 
Feng, T. P. and Li, T. H. (1941). Studies on the neuromuscular junction. 
XXIII. A new aspect of the phenomena of eserine 
potentiation and post-tentanic facilitation in mammalian 
muscles, Chin. J. Physiol., 16, 37-56. 
Ferko, A. P. and Calesnick, B. (1971). L-DOPA and dopamine on skeletal 
muscle, Res. Commun. Chem. Pathol. Pharmacol., 
2, 146-153. 
Fiker, S. (1955). Paper chromatographic division of multivalent phenoles, 
Chem. Abstr., 49, 3734. 
Folkow, B., Haggendal, J. and Lisander, B. (1968). Extent of release and 
elimination of noradrenaline at peripheral adrenergic 
nerve terminals, Acta Physiol. Scand., 72, Suppl. 307, 
6-38. 
Friedenwald, J. S. and Hermann, H. (1942). Inactivation of amine oxidase 
by enzymatic oxidative products of catechol and adrenalin, 
J. Biol. Chem., 146, 411-419. 
Furshpan, E. J. (1956). The effects of osmotic pressure changes on the 
spontaneous activity of motor nerve endings, J. Physiol. 
(London), 134, 689-697. 
Gage, P. W. and Hubbard, J.I. (1965). Evidence for a Poisson distribution of 
mepps and some implications, Nature, 208, 395-396. 
Gage, P. \V. and Quastel, D. M. J. (1966). Competition between sodium and 
calcium ions in transmitter release at a mammalian 
neuromuscular junction, J. Phys_iol. (Nature), 185, 
95-123. 
Gatgounis, J. and Walton, R. P. (1958). Cerebral site of action of compounds 
with conspicuous pressor and inotropic effects, Fed. 
Proc., 17, 370. 
Gatgounis, J. and Walton, R. P. (1960). Resorcinol isomers and metrazole; 
their centrally mediated sympathetic circulatory effects, 
J. Pharmacol. Exp. Ther., 128, 363-371. 
159 
Goffart, M. and Holmes, 0. (1962). The effects of adrenaline on mammalian 
"C" and "A" nerve fibers, J. Physiol. {London), 162, 
18-19P. 
Goffart, M. and Ritchie, J.M. {1952). The effect of epinephrine on the 
contraction of mammalian skeletal muscle, Amer. J. 
Physiol., 34, 89-96. 
Goldberg, A. L. and Singer, J. J. {1969). Evidence for a role of Cyclic-AMP 
in neuromuscular transmission, Proc. Nat. Acad. Sci., 
64, 134-141. 
Goldstein, Avram, Biostatistics: An Introductory Text, The Macmillan 
Company, New York, {1969). 
Goodman, L. S. and Gilman A. {Edits) The Pharmacological Basis of 
Therapeutics, 4th Edition, The Macmillan Company, New 
York, {1970). 
Graham, J. and Gerard, H. W. {1946). Membrane potentials and excitation 
of impaled single muscie fibers, J. Cell. Comp. Physiol., 
28, 99-ll7. 
Grob, D., Johns, H.J. and Harvey, A. M. {1956). Studies in neuromuscular 
functions. IV. Stimulating and depressant effects of 
acetylcholine and choline in patients with myasthenia gra-
vis, and their relationship to the defect in neuromuscular 
transmission, Bull. Johns Hopkins Hosp., Q_~, 153-181. 
Gruber, C. lVI. {1914). Studies in fatigue. IV. The relation of adrenalin to 
curare and fatigue in normal and denervated muscles, 
Amer. J. Physiol., 34, 89-96. 
Harold, C.H., Nierenstein, M. and Roaf, H. E. {1911). The influence of the 
presence and position of the vari~us radicles of adrenalin 
on its physiological activity, J. Physiol. {London), 41, 
308-317. 
Harvey, A. M. {1939). Action of procaine on neuromuscular transmission, 
Bull. Johns Hopkins Hosp., 65, 223-238. 
160 
Harvey, A. M. and Macintosh, F. C. (1940). Calcium ions and synaptic 
transmission in sympathetic ganglion, J. Physiol. 
(London), 97, 408-416. 
Hebb, C. O. and Waites, G. M. H. (1956). Choline acetylase in antero and 
retrograde degeneration of a cholinergic nerve, J. 
Physiol. (London), 132, 667-671. 
Hebb, C. O. and Smallman, B. N. (1956). Intracellular distribution of 
choline acetylase, J. Physiol. (London), 134, 385-392. 
Hobbiger, F. (1952). The mechanism of anti-curare action of certain neo-
stigmine analogues, Brit. J. Pharmacol. Chemother., 
7' 223-236. 
Hodgkin, A. L. and Katz, B. (1949). The effect of sodium ions on the 
electrical activity of the giant squid axon of the squid, 
J. Physiol. (London), 108, 37-77. 
Hodgkin, A. L. (1950). Conduction of nervous impulse; some recent experi-
ments, Brit. Med. Bull., 6, 322-325. 
Hodgkin, A. L. (1951). The ionic basis of electrical activity in nerve and 
muscle, Biol. Rev., 26, 339-409. 
Hodgkin, A. L. (1958). The Croonian Lecture. Ionic movements and electrical 
activity in giant nerve fibers, Proc. Roy. Soc. (London), 
B., 148, 1-37. 
Hodgkin, A. L., The Conduction of the Nervous Impulse, Liverpool Universit 
Press, Liverpool (1967). 
Hodgkin, A. L. and Keynes, R. D. (1957). Movements of labelled calcium in 
squid giant axons, J. Physiol. (London), 138, 253-281. 
Hodgkin, A. L. and Horowitz, P. (1959). The influence of potassium and 
chloride ions on the membrane potential of single muscle 
fibers, J. Physiol. (London), 148, 127-160. 
Hofmann, W.W. (1969). Caffeine effects on transmitter depletion and mobili-
zation at motor nerve terminals, Amer. J. Physiol. , 
216, 621-629. 
161 
Hoppe, J. O. {1951). A new series of synthetic curare-like compounds, Ann. 
N. Y. Acad. Sci., 54, 395-406. 
Hubbard, J. I. (1961). The effect of calcium ion and magnesium ion on the 
·spontaneous release of transmitter from mammalian 
motor nerve endings, J. Physiol. (London), 159, 507-517. 
Hubbard, J. I. (1963). Repetitive stimulation at the mammalian neuro-
muscular junction, and the mobilization of transmitter, 
J. Physiol. (London), 169, 641-662. 
Hubbard, J. I., Jones, S. F. and Landau, E. M. (1967). The relationship 
between the state of nerve terminal polarization and 
liberization of acetylcholine, Ann. N. Y. A cad. Sci., 
144, 459-469. 
Hubbard, J. I., Jones, S. F. and Landau, E. M. {1968). On the mechanism 
by which calcium ions and magnesium ions affect the 
spontaneous release of transmitter from mammalian 
motor nerve terminals, J. Physiol. (London), 194, 
355-380. 
Hubbard, J". I., Jones, S. F., and Landau, E. M. {1968). An examination of 
the effects of osmotic pressure changes upon transmitter 
release from mammalian motor nerve terminals, J. 
Physiol. (London), 197, 639-657. 
Hubbard, J. I. and Kwanbunbumpen, S. (1968). Evidence for the vesicle 
hypothesis, J. Physiol. (London), 194, 407-420. 
Hubbard, J. I., Llimf s, R. and Quastel, D. M. J. Electrophysiological 
Analysis of Synaptic Transmission, Williams and Wilkins, 
Co., Baltimore, Md., (1969). 
Hubbard, J. I. and Schmidt, R. F. (1963). An electr<;>physiological investi-
gation of mammalian motor nerve terminals, J. Physiol. 
(London), 166, 145-167. 
Hubbard, J. I., Schmidt, R. F. and Yokota, T. (1965). The affect of 
acetylcholine upon mammalian motor nerve terminals, 
J. Physiol. (London), 181, 810-820. 
Hubbard, J. I. and Willis, W. D. (1962). Hyperpolarization of mammalian 
motor nerve terminals, J. Physiol. (London), 163, ll5-137. 
162 
Hubbard, J. I. and Willis, W. D. (1962). Reduction of transmitter output by 
depolarization, Nature, 193, 1294-1295. 
Hubbard, J. I., Wilson, D. F. and Miyamoto, M. (1969). Reduction of trans-
mitter release by d-tubocurarine, Nature, 223, 531-533. 
Hunt, R. and Taveau, R. deM. (1906). On the physiologic action of certain 
choline derivatives and new methods for detecting 
choline, Brit. Med. J.·, 2, 1788-1791. 
Hutter, O. F. and Kostial, K. {1954). Effect of magnesium and calcium ions 
on the release of acetylcholine, J. Physiol. (London), 
124, 234-241. 
Hutter, O. F. and Loewenstein, W.R. (1955). Nature of neuromuscular 
facilitation by sympathetic stimulation in the frog, J. 
Physiol. (London), 130, 559-571. 
Jenkinson, D. H., Stamenovic, B. A. and Whitaker, B. D. L. {1968). The 
effect of noradrenaline on the endplate potential in 
twitch fibers of the frog, J. Physiol. (London), 195, 
743-754. 
Johnson, E. S. {1962). The spasmolytic actions of pyrogallol and catechol 
on the isolated guinea pig ileum, J. Pharm. Pharmacol., 
14, 272-279. 
Karczmar, A.G. Pharmacologic effects of newer bisquaternary anti-
cholinesterases, particularly at the neuromyal junction. 
In: Bioelectrogenesis, Edit. C. Chagas and A. P. de 
Carvalho, Elsevier Publishing Co., Amsterdam, pp. 
320-340, 1961. 
Karczmar, A.G. {1967a) Neuromuscular Pharmacology, Annu. Rev. 
Pharmacol., 7, 241-276. 
Karczmar, A.G., Pharmacologic, toxicologic and therapeutic properties of 
anticholinesterase agents, In: Physiological Pharmacology 
Edit. W. S. Root and F. G. Hofmann, Volume 3, Academic 
Press, New York, pp. 164-322, (1967b). 
163 
Karczmar, A.G. Introduction: History of the research with anticholinester-
ase agents. In: Anticholinesterase Agents, Edit. A.G. 
Karczmar. Pergamon Press, London-New York, Vol. I., 
pp. 1-44, (1970). 
Karczmar, A.G., Nishi, S. and Blaber, L. C. (1970). Investigations, 
particularly by means of anticholinesterase agents, of the 
multiple, peripheral and central cholinergiC mechanisms 
and of their behavioral implications, Acta Vitaminologica 
Et Enzymologica, 24, 131-189. 
Karczmar, A.G. and Nishi, S. The types and sites of cholinergic rec~ptors, 
In: Advances in Cytopharmacology, Edit. F. Clementi and 
B. Ceccarelli, Vol. I, pp. 301-318, 1971. 
Katz, B. (1958) Microphysiology of the neuro-muscular junction, Bull. 
Johns Hopkins Hosp., 102, 275-312. 
Katz, B. (1962) The transmission of impulses from nerve to muscle, and the 
subcellular unit of synaptic action, Proc. Hoy. Soc. 
London B., 155, 455-477. 
Katz, B., Nerve, Muscle and Synapse, McGraw-Hill, New York, 
(1966). 
Katz, B. and Miledi, H. (1964). Localization of calcium ion action at the 
nerve muscle junction, J. Physiol. (London), 171, 
10-12P. 
Katz, B. and Miledi, H. (1965). The effect of calcium on acetylcholine and 
release from motor nerve endings, Proc. Hoy. Soc. 
London B., 161, 496-503. 
Katz, B. and Miledi, R. (1967a). The timing of calcium ion action during 
neuromuscular transmission, J. Physiol. (London), 
189, 535-544. . 
Katz, B. and Miledi, H. (1967b). A study of synaptic transmission in the 
absence of nerve impulses, J. Physiol. (London), 192, 
407-436. 
164 
Katz, B. and Miledi, R. (1967c). Ionic requirements of synaptic trans-
mitter release, Nature, 215, 651. 
Katz, B. and Thesleff, S. (1957). On the factors which determine the 
amplitude of the "mepp", J. Physiol. (London), 137, 
267-278. 
Kelly, J. A. (1965). Antagonism between sodium ion and calcium ion at the 
neuromuscular junction, Nature, 205, 296-297. 
Kim. K. C. and Karczmar, A.G. (1967). Adaptation of the neuromuscular 
junction to constant concentration of acetylcholine, Int. 
J. N europharmacol. , 6, 51- 61. 
King, Harold (1935). Curare alkaloids. Part I. Tubocurarine., J. Chem. 
Soc., II, 1381-1389. 
Koelle, G. B. (1962). A new concept of the neurohumoral functions of 
acetylcholine and acetylcholinesterase, J. Pharm. 
Pharmacol., 14, 65-90. 
Koelle, G. B. (1963). Cytological distributions and physiological functions 
of cholinesterase, Hanb. Exp. Pharm., Suppl. 15, 
178-298. 
Koelle, G. B. and Friedenwald, J. S. (1949). A histochemical method for 
localizing cholinesterase activity, Proc. Soc. Exptl. 
Biol. Med., 70, 617-622. 
Koelle, G. B. and Steiner, E. C. (1956). The cerebral distribution of a 
tertiary and a quaternary anticholinesterase agent 
following intravenous and intra ventricular injection, J. 
Pharmacol. Exp. Ther., 118, 420-434. · 
Kordas, M. (1968). The effect of atropine and curarine on the time course 
of the endplate potential in frog s·artorius muscle, Int. 
J. Neuropharmacol., '!_, 523-530. 
Krebs, H. A. and Henseleit, K. (1932). Untersuchen uber die harnstoff-
bildung im tier korper, Z. Physiol. Chem. (Hoppe-
Seyler's) 210, 33-66. 
Krnjevic, K. and Miledi, R. (1958a). Failure of neuromuscular propogation 
in rats, J. Physiol. (London), 140, 440-461. 
165 
Krnjevic, K. and Miledi, R. (1958b). Some effects produced by adrenaline' 
upon neuromuscular propogation in rats, J. Physiol. 
(London), 141, 291-304. 
Kuba, Kenji, (1969). The action of phenol on neuromuscular transmission in 
• the red muscle of the fish, Jap. J. Physiol., :i9, 
762-77 4. 
Kuba, K. (1970). Effects of catecholamines on the neuromuscular junction of 
the rat diaphragm, J. Physiol. (London), 2ll, 551-570. 
Kuno, l\II. (1964). Quantal components of excitatory post-synaptic potentials 
in spinal motoneurones, J. Physiol. (London), 175, 
81-99. 
Kuperman, A. S., Gill, E.W. and Riker, W. F. (1961). The relationship 
between cholinesterase inhibition and drug induced 
facilitation of mammalian neuromuscular transmission, 
J. Pharmacol. Exp. Ther., 132, 65-73. 
LaBrosse, E. H. and Axelrod, J. and Kety, S.S. (1958). 0-methylation, the 
principal route of metabolism of epinephrine in man, 
Science, 128, 593-594. 
Libet, B. (1970). Generation of slow inhibitory and excitatory postsynaptic 
potentials, Fed. Proc., 29, 1945-1956. 
Liddell, E.G. T. and Sherrington, C. (1924-25). Recruitment and some other 
features of reflex inhibition, Proc. Roy. Soc. London B., 
97' 488-518. 
Liley, A. W. (1956a). An investigation of spontaneous activity at the neuro-
muscular junction of the rat, J. Physiol. (London), 132, 
650-666. 
Liley, A. W. (1956b). The quanta! components of the mammalian endplate 
potential, J. Physiol. (London), 133, 571-587. 
Liley, A. W. (1956c). The effect of presynaptic polarization on the 
spontaneous activity at the mammalian neuromuscular 
junction, J. Physiol. (London), 134, 427-443. 
166 
Liley, A. W. and North, K. A. K. (1953). An electrical investigation of 
effects of repetitive stimulation on mammalian neuro-
muscular junction, J. Neurophysiol. , 16, 509-527. 
Lister, Joseph, (1867). On the antiseptic principle in the practice of surgery, 
Lancet, 2, 353-356. 
Loewi, 0. (1921). Uber humorale uber tragbarkeit der herznervenwirkung. 
X. Mitteilung. Uber das schicksal des vagusstoffs, 
Pfluegers Arch. Gesamte Physiol menshen tiere, 214, 
678-688. 
Long, J.P. and Schueler, F. W. (1954). A new series of cholinesterase 
inhibitors, J. Amer. Pharm. Assn. Sci. Ed., 43, 
79-86. 
Lundberg, A. and Quilisch, H. (1953). On the effect of calcium ion on 
presynaptic potentiation and depression at the neuro-
muscular junction, Acta Physiol. Scand., 30, 
Suppl. III, 121-129. 
Maclagen, J. (1962). A comparison of the responses of the tenuissimus 
muscle to neuromuscular blocking drugs in vivo and 
in vitro, Brit. J. Pharmacol. Chemother-:-: TI:-
204-216. 
Maddock, W. O., Rankin, V. M. and Youmans, W. B. (1948). Prevention 
of the anti-curare action of epinephrine by dibenamine, 
Proc. Soc. Exp. Biol. Med., 67, 151-153. 
Mann, P.J. G., Tennenbaum, M. and Quastel, J.H. (1938). On the 
mechanism of acetylcholine formation in brain in vitro, 
Biochem. J., 32, 243-261. - --
Martin, A. R. (1955). A further study of the statistical composition of the 
endplate potential, J. Physiol. (London), 130, 
114-122. 
Martin, A. R. (1966). Quanta! nature of synaptic transmission, Physiol. 
Rev., 46, 51-66. 
167 
Masland, R. L. and Wigton, R. S. (1940). Nerve activity accompanying 
fasciculation produced by prostigmine, J. Neurophysiol. , 
3, 269-275. 
Matsumoto, J. , Kiyono, S., Nishi, H., Koike, J. and lchihashi, T. (1963). 
The convulsive mechanism of phenol derivatives, Med. 
J. Osaka Univ., 13, 313-323. 
Matsumoto, J. and Nishi, H. (1963a). Functional mechanism of catechol in 
the central nervous system. I. The anatomic site of 
action, Med. J. Osaka Univ., 13, 365-373. 
Matsumoto, J. and Nishi, H. (1963b). Functional mechanism of catechol in 
the central nervous system. II. The physiochemical 
site of action, Med. J. Osaka Univ., 13, 375-386. 
Miledi, R., Molinoff, P. and Potter, L. T. (1971). Isolation of the cholin-
ergic receptor protein of torpedo electric tissue, Nature, 
229, 554-557. 
Mizuno, T. (1934). Uber die wirkung der phenole auf die muskelzuckungen, 
Jap. J. Med. Sci. Biophysics, ~· 56-58. 
Mogey, G. A. and Young, P.A. (1949). The antagonism of curarizing activity 
by phenolic substances, Brit. J. Pharmacol. Chemother., 
4, 359-365. 
Muhlmann, M. (1896). Zur physiologie der nebenniere, Deut. Med. 
Wochenschr., 22, 409-412. 
Mulinos, M. G. and Osborne, R. L. (1935a). A note on the analysis of 
sympatheticomimetic action, Proc. Soc. Exp. Biol.. 
Med., 33, 458. 
Mulinos, M. G. and Osborne, R. L. (1935b). Physiological activity of some 
catechol derivatives, Proc. Soc. Exp. Biol. Med. 
32, 1344-1346. 
168 
Nachmansohn, D., The neuromuscular junction. In: The Structure and 
Function of Muscle, Edit. G. H. Bourne, Vol. 2, 
Academic Press, New York and London, pp. 199-295, 
(1960) 
Naess, K. and Sirnes, T. (1953). A synergistic effect of epinephrine and 
d-tubocurarine on the neuromuscular transmission, 
Acta Physiol. Scand., 29, 293-306. 
Nishi, S. and Koketsu, K. (1960). Electrical properties and activities of 
single sympathetic neurons in frogs, J. Cell. Comp. 
Physiol., 55, 15-30. 
Okamoto, M. and Hiker, W. F. Jr. (1969). Subacute denervation: a means of 
disclosing mammalian motor nerve terminals as 
critical sites of acetylcholine and facilitatory drug 
actions, J. Pharmacol. Exp. Ther., 166, 217-224. 
Oliver, G. and Schafer, E. A. (1895). The physiological effects of supra-
renal capsules, J. Physiol. (London), 18, 230-276. 
Osborne, R. L. (1937). Studies in sympatheticomimicity; physiologic 
effects of more non-amino catechol derivatives, Proc. 
Soc. Exper. Biol. Med., 35, 567-570. 
Otsuka, M. and Endo, M. (1960a). The effect of guanidine on neuromuscular 
transmission, J. Pharmacol. Exp. Ther., 128, 
273-282. 
Otsuka, M. and Endo, M. (1960b). Presynaptic nature of neuromuscular 
depression in the frog, Nature, 188, 501-502. 
Otsuka, M. , Endo, M. and Nonomura, Y. (1962). Pre-synaptic nature of 
neuromuscular depression, Jap. J. Physiol., 12, 
537-584. 
Otsuka .. M. and Nonomura, Y. (1963). The action of phenolic substances on 
motor nerve endings, J. Pharmacol. Exp. Ther., 140, 
41-45. 
169 
Palade, G. E. and Palay, S. L. (1954). Electron mi~roscope observations on 
interneuronal and neuromuscular synapses, Anat. Rec., 
118, 335-336. 
Palay, S. L. (1958). The morphology of synapses in the central nervous 
system, Exp. Cell Res. Suppl., ~' 275-293. 
Panella, A. (1907). Action du principe actif surrenal sur la fatigue 
musculaire, Arch. Ital. Biol., 48, 430...,463. 
Perry, W. L. (1953). Acetylcholine release in the cat's superior cervical 
ganglion, J. Physiol. (London), 119, 439-454. 
Pilar, G. (1969). Effect of acetylcholine on pre- and post-synaptic elements 
of avian ciliary ganglion synapses, Fed. Proc., 
28, 670. 
Porter, E. L. and Hart, V. W. (1923). Reflex contractions of an all-or-none 
character in the spinal cat, Amer. J. Physiol., 66, 
391-403. 
Potter, L. T. (1968). Turnover of acetylcholine-14c in rat hemidiaphragms. 
Proc. Physiol. Soc., 13-14th Dec., 3-5P. 
Reger, J. F. (1954). Electron microscopy of the motor end-plate in 
intercostal muscle of the rat. Anat. Rec., 118, 344. 
Reger, J. F. (1957). The ultrastructure of normal and denervated neuro-
muscular synapses in mouse gastrocnemius muscle, 
Exp. Cell Res. , 12, 662-665. 
Hemen, L. (1932). Zur pathogenese und therapie der myasthenia gravis 
pseudoparalytic, Dt. Z. Nerv. Heilk., 128, 
66-78. 
Riker, W. F.Jr. (1953). Excitatory and anti-curare properties of acetyl-
choline and related quaternary ammonium compounds 
at the neuromuscular junction, Pharmacol. Rev., 5, 
1-86. 
170 
Riker, W ... F. Jr. (1960). Pharmacologic considerati<;>ns in a re-evaluation of 
the neuromuscular synapses, Arch. Neural., ~' 488-499. 
Riker, W. F. Jr. (19 66). The actions of acetylcholine on mammalian motor 
. nerve terminals, J. Pharm. Pharmacol., 152, 397-416. 
Riker, W. F. Jr. (1969). Pharmacology of motor nerve terminals, Annu. 
Rev. Pharmacol., 9, 173-208. 
Riker, W.F.Jr., J. Standaert, F.G. andFujimori, H. (1957). The motor 
nerve terminal as the primary focus for drug-induced 
facilitation of neuromuscular transmission, J. 
Pharmacol. Exp. Ther., 121, 286-312. 
Riker, W. F. Jr. and Standaert, F. G. (1966). The action of facilitatory drugs 
and acetylcholine on neuromuscular transmission, Ann. 
N. Y. Acad. Sci., 135, 163-176. 
Robertson, J. D. (19 54). Electron microscope observations on a reptilian 
myoneural junction, Anat. Rec., 118, 346. 
Robertson, J. D. (1956). The ultrastructure of the reptillian myoneural 
junction, J. Biophys. Bio chem. Cytol. , ~' 381-394. 
Robertson, J. D. (1960). Electronmicroscopy of the motor endplate and the 
neuromuscular spindle, Am. J. Phys. Med., ~' 1-43. 
Robison, G. A. Butcher, R. W. and Sutherland, E.W. (1967). Adenyl cyclase 
as an adrenergic receptor, Ann. N. Y. A cad. Sci., 
139, 703-723. 
Rogers, K. J., Angel, A. and Butterfield, L. (1968). The penetration of 
catechol and pyrogallol into mouse brain and the effect 
on cerebral monoamine levels, J. Pharm. Pharmacol. , 
20, 727-729. 
Rothberger, C. J. (1902). Weitere mittheilungen uber antagonisten des 
curarins, Pfluegers Arch. Gesamte Physiol. menschen 
tiere, 92, 398-450. 
Shuster, Louis (Edit.), Readings in Pharmacology, Little, Brown and 
Company, Boston, (1962). 
171 
Sherrington. C. S. (1910). Flexion-reflex of the limb, .. crossed extension 
reflex, and reflex stepping and standing, J. Physiol. 
(London). 40, 28-121. 
Sherrington, C. S. (1921). Break-shock reflexes and "supramaximal" 
contraction response of mammalian nerve muscle to 
single shock stimuli, Proc. Roy. Soc. London B., 92. 
245-258. 
Sjostrand, N. (1960). The effect of catechol on the isolated guinea pig 
ileum, Acta Physiol. Scand., 49, 57-61. 
Sjostrand, N. (1961). Further studies on the effect of catechol on the 
isolated guinea pig ileum, Acta Physiol. Scand .• 52, 
343-349. 
Standaert, F.G. and Roberts, J. (1967). A neural action of pronethalol, 
Ann. N. Y. A cad. Sci., 139, 815-820. 
Stajrne, L., Hedqvist, P. and Bygdeman, S. (1969). Neurotransmitter 
quantum released from sympathetic nerves in cat skeletal 
muscle, Life Sci.. Oxford, 8, 189-197. 
Sutherland, E.W. and Robison, G. A. (1966). The role of cyclic-3', 5' -AMP 
in response to catecholamines and other hormones, 
Pharmacol. Rev., 18, 145-161. 
Tainter, M. L. (1930). Comparative actions of sympathomimetic compounds; 
catechol derivatives, J. Pharmacol. Exp. Ther., 40, 
43-64. 
Takagi, K. and Takayanagi, I. (1965). Effects of aromatic nitro compounds 
and phenol derivatives on the cholinergic nerve endings of 
smooth and skeletal muscle, Arch. Int. Pharmacodyn .• 
155. 373-380. 
Takeuchi, A. (1959). Neuromuscular transmission of fish skeletal muscles 
investigated with intracellular microelectrodes, J. Cell. 
Comp. Physiol., 54, 211-270. 
Takeuchi, N. (1963). Effects of calcium ion on the conductance change of the 
endplate potential membrane during the action of trans-
mitter, J. Physiol. (London), 167, 141-155. 
172 
Takeuchi, A. and Takeuchi, N. (1959). Active phase.of frog's endplate 
potential, J. Neurophysiol., ~, 395-411. 
Takeuchi, A. and Takeuchi, N. (1960). On the permeability of end-plate 
membrane during the action of transmitter, J. Physiol. 
(London), 154, 52-67. 
Talbott, J. H. (Edit.) (1965). Peripheral phenol injections reduce spasticity, 
J. Amer. Med. Assn., 193, No. 12, 31-33. 
Thesleff, S. (1955). Neuromuscular block caused by acetylcholine, Nature, 
175, 594-595. 
Thesleff, S. (1960) Effects of motor innervation on the chemical sensitivity 
of skeletal muscle, Physiol. Rev., 40, 734-752. 
Thesleff, S. and Quastel, D. M. (1965). Neuromuscular pharmacology, 
Annu. Rev. Pharmacol., 5, 263-284. 
Todd, R. G. (Edit.), Extra Pharmacopoeia Martindale, 25th. Edition. The 
Pharmaceutical Press, London, pp. 1441-1442, (1967). 
Usubiaga, J.E. (1968). Neuromuscular effects of beta-adrenergic blockers 
and their interaction with skeletal muscle relaxants, 
Anesthesiology, 29, 484-492. 
vonEuler, U.S. and Lishajko, F. (1959). Excretion of catechol in human 
urine, Nature, 183, 1123. 
Walker, Mary, B. (1935). Case showing effect of prostigmine on myasthenia 
gravis, Proc. Roy. Soc. Med., 28, 759-761. 
Walton, R. P., Walton, R. P. Jr., and Thompson, W. L. (1959). Inotropic 
activity of catechol isomers and a series of related 
compounds, J. Pharmacol. Exp. "Ther., 125, 202-207. 
Werner, G. (1960). Neuromuscular facilitation and antidromic discharges 
in motor nerves; their relation to activity in motor 
nerve terminals, J. Neurophysiol., 23, 171-187. 
White, R. P., Sewell, H. H. Jr. and Rudolph, A. S. (1965). Drug induced 
dissociation between evoked reticular potentials and the 
EEG, Electroencephalogr. Clin. Neurophysiol., 19, 16-24. 
173 
Wilson, A. T. and Wright, S. (1937). Anti-curare action of potassium and 
other substances, Quart. J. Exp:· Physiol. Cog. Med. 
Sci., 26, 127-139. 
Wilson, C. O. and Gisvold, O. , Textbook of Organic Medicinal and Pharma-
ceutical Chemistry, 4th Edition, Lippincott, Philadelphia, 
(1962). 
Wolf, S. M., Rowland, L. P., Schotland, D. L., McKinney, A. S., Hoefer, 
P.F.A., Aranow, H.Jr. (1966). Myasthenia as an 
autoimmune disease: clinical aspects, Ann. N. Y. Acad. 
Sci., 135, 517-535. 
Wylie, D. W., Archer, S. and Arnold, A. (1960). Augmentation of pharma-
cological properties of catecholamines by 0-methyl 
transferase inhibitors, J. Pharmacol. Exp. Ther., 
130, 239-244. 
Zacks, Sumner, I., The Motor End Plate, W. B. Saunders Co., Philadel-
phia, London, (1964). 
Zacks, S. I. and Blumberg, J.M. (1961). Observations on the fine 
structure of mouse and human neuromuscular junctions, 
J. Biophys. Biochem. Cytol., 10, 517-528. 
Zaimis, E. J. (1953). Motor endplate differences as a determining factor 
in the mode of action of neuromuscular blocking 
substances, J. Physiol. (London), 122, 238-251. 
174 
APPROVAL SHEET 
The dissertation submitted by Joel P. Gallagher has been read and 
approved by a committee composed of Alexander H. Friedman, Ph.D., 
John I.. Hubbard, D.M., Ph.D., Kenji Kuba, M.D., Ph.D., Syogoro 
Nishi, M.D., Ph.D., Yvo T. Oester, M.D., Ph.D. and Alexander G. 
Karczmar, M. D., Ph.D. (Chairman). 
The final copies of the dissertation have been examined by the 
chairman of the examining committee and his signature which appears 
below verifies that all the necessary changes have been incorporated 
and that the dissertation is now given final approval with reference to 
content, form and mechanical accuracy. 
The dissertation is therefore accepted in partial fulfillment of the 
requirements for the Degree of Doctor of Philosophy. 
i---------------------~.-.....:v.n~,_.., _________ _ 
